WO2021215411A1 - Skin anti-aging agent, beautification method for skin anti-aging, and beautification instrument for use in method - Google Patents
Skin anti-aging agent, beautification method for skin anti-aging, and beautification instrument for use in method Download PDFInfo
- Publication number
- WO2021215411A1 WO2021215411A1 PCT/JP2021/015926 JP2021015926W WO2021215411A1 WO 2021215411 A1 WO2021215411 A1 WO 2021215411A1 JP 2021015926 W JP2021015926 W JP 2021015926W WO 2021215411 A1 WO2021215411 A1 WO 2021215411A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- cells
- stimulus
- aging
- yap
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention relates to a skin anti-aging agent, a cosmetological method for skin anti-aging, and a cosmetological device for applying to the method.
- Skin aging is a change in the skin mediated by various factors including internal factors such as aging, hormones and metabolism, and external factors such as ultraviolet rays and dryness. Skin aging may be judged from the appearance such as spots, wrinkles, sagging, and deflation, but invisible aging such as changes in the structure and constituents of the internal tissues of the skin may be progressing. It is difficult to take preventive measures because such aging often progresses without being noticed. It is important to take appropriate measures to prevent and improve skin aging.
- Patent Document 1 discloses an electroactive material actuator that causes displacement of a keratinous substance.
- Patent Document 2 discloses a light irradiation beauty device that irradiates light with the skin stretched.
- Patent Document 3 discloses a slimming method for reducing subcutaneous fat by combining a stretch that stretches subcutaneous adipocytes and an external skin preparation containing an adipocyte accumulation inhibitor and / or an adipocyte differentiation inhibitor.
- Patent Document 4 discloses an extension-stimulating-mediated collagen-degrading enzyme production inhibitor containing an extract of a plant of the genus Oat or an extract of a plant of the genus Psoralea.
- Patent Document 5 discloses a wrinkle improving agent or an NF- ⁇ B activity inhibitor caused by extension stress.
- Non-Patent Document 1 recommends mechanical stimulation at 65 to 85 Hz.
- Patent Document 6 related to the apparatus described in Non-Patent Document 1 discloses a terminal effector that stimulates the skin at a frequency of about 65 to about 120 Hz.
- Non-Patent Document 2 a structurally very characteristic basement membrane just below the epidermis (undulation structure), and it is highly likely that it will receive mechanical stimuli. It has also been reported that the surface layer is significantly changed by actually giving a physical stimulus according to the prior literature (Non-Patent Document 2). Therefore, there is a need for skin anti-aging agents, methods and devices that have a favorable anti-aging effect on the skin including the epidermis and basement membrane.
- An object of the present invention is to provide a skin anti-aging agent, a cosmetological method for skin anti-aging, and a cosmetological device for applying to the method.
- the present inventors have conducted a physical stimulus on the skin when a composition containing arabinoxylan is applied to the skin or when a physical stimulus such as extension is applied to the skin at a specific extension rate and frequency. It was discovered that the number of cells having a decreasing nuclear localization YAP and / or a cell having an actin stress fiber is increased to exert a skin anti-aging effect, and the present invention was conceived. That is, the present application provides the following inventions: [1] A skin anti-aging agent containing arabinoxylan as an active ingredient. A skin anti-aging agent characterized by increasing cells with nuclear localized YAP and / or actin stress fibers that are reduced by physical stimulation in the skin.
- the skin anti-aging agent according to item 1 wherein the arabinoxylan is derived from rye.
- the skin anti-aging agent according to item 1 or 2 wherein the arabinoxylan is derived from Kohiris TM GR.
- a cosmetic method for skin anti-aging that increases cells having nuclear-localized YAP and / or actin stress fibers that decrease due to physical stimulation in the skin.
- (A) Applying the skin anti-aging agent according to any one of items 1 to 3 to the target skin, Cosmetology methods, including.
- the cosmetological method further includes a step of applying a weak physical stimulus to the skin, wherein the step of applying the physical stimulus is, for example, for example.
- the target skin is stretched to a stretch rate of 0.1% or more and 50.0% or less, where the stretch rate is defined as.
- the fixed points A and B are arbitrary positions on the epidermis or the matrix to which the epidermis is adhered, and the straight line passing through the fixed points A and B is parallel to the extension direction).
- the device is The stimulus generator that causes physical stimulus and It is equipped with a stimulus-giving part that gives the physical stimulus generated in the stimulus-generating part to the skin.
- the device is a device for performing a step of applying a weak physical stimulus to the skin, and the step is described here, for example.
- a cosmetological method for skin anti-aging which comprises applying the cosmetological device according to item 9 to the target skin.
- a skin anti-aging agent that increases cells having nuclear-localized YAP and / or cells having actin stress fibers, which are reduced by physical stimulation in the skin, and exerts a preferable skin anti-aging effect on a shallow layer such as the epidermis. Beauty methods and beauty devices for use in those methods are provided. As a result, prevention and improvement of skin aging such as age spots, wrinkles, and sagging are expected.
- FIG. 1 shows the setting of the extension stimulus performed in Experiments 1 and 3.
- FIG. 2a shows the localization of YAP (red) and actin (green) in a monolayer culture of keratinocytes obtained from a 44-year-old donor in Experiment 1 without stretching stimulus and immediately after giving.
- FIG. 2b shows YAP (red) and actin in a state in which the monolayer culture of keratinocytes obtained from donors (0 years old, 18 years old, 64 years old) of each age in Experiment 1 was not stimulated for extension and immediately after the application. (Green) indicates localization.
- FIG. 1 shows the setting of the extension stimulus performed in Experiments 1 and 3.
- FIG. 2a shows the localization of YAP (red) and actin (green) in a monolayer culture of keratinocytes obtained from a 44-year-old donor in Experiment 1 without stretching stimulus and immediately after giving.
- FIG. 2b shows YAP (red) and actin in a state in which the
- FIG. 3 shows the number of cells having nuclear localization YAP immediately after the keratinocyte culture obtained from donors (0 years old, 18 years old, 62 years old) of each age in Experiment 1 without extension stimulation. Shows the percentage. In the figure, * indicates that there is a significant difference by the two-sided t-test (when the variances of the two populations are equal) (p ⁇ 0.05%).
- FIG. 4 shows the ratio of the number of cells having actin stress fibers immediately after the keratinized cell culture obtained from donors (0 years old, 18 years old, 62 years old) of each age in Experiment 1 without the extension stimulation. Is shown.
- FIG. 5 shows YAP (red), actin (green), and actin (green) in the state in which the culture of fibroblasts obtained from donors (0 years old, 68 years old) of each age in Experiment 1 was not stimulated for extension and immediately after the culture was given. Shows the localization of the nucleus (blue).
- FIG. 6 shows the apparatus used in Experiment 2 and an ex vivo skin sample.
- FIG. 7 shows the setting of the extension stimulus performed in Experiments 2, 4 and 5.
- FIG. 5 shows YAP (red), actin (green), and actin (green) in the state in which the culture of fibroblasts obtained from donors (0 years old, 68 years old) of each age in Experiment 1 was not stimulated for extension and immediately after the culture was given. Shows the localization of the nucleus (blue).
- FIG. 6 shows the apparatus used in Experiment 2 and an ex vivo skin sample.
- FIG. 7 shows the setting of the extension stimulus performed in Experiments 2, 4 and 5.
- FIG. 8 shows the localization of YAP (green) and nucleus (blue) immediately after the skin sample obtained from a 44-year-old donor in Experiment 2 without pressing stimulation.
- FIG. 9 shows a condition in which a monolayer culture of keratinocytes obtained from a 44-year-old donor in Experiment 3 was not given a stretch stimulus, a condition in which one stretch stimulus was given, and a condition in which two stretch stimuli were given. After that, the localization of YAP and BrdU after normal culture for 1 week is shown.
- FIG. 10 shows the device and skin sample used in Experiment 4. In FIG.
- FIG. 14 shows an example of the apparatus of the present invention.
- FIG. 15 shows immediately after adding 0.3% by weight and 1.0% by weight of Kohiris TM GR to the monolayer culture obtained from a 44-year-old donor in Experiment 6 and giving a single extension stimulus. The localization of YAP (red) and actin (green) is shown (top). The lower left of FIG. 15 shows the ratio of the number of cells having nuclear localization YAP.
- FIG. 15 shows the ratio of the number of cells having actin stress fibers.
- *** indicates that there is a significant difference due to the two-sided t-test (when the variances of the two populations are equal) (p ⁇ 0.05%).
- FIG. 16a shows the measurement results by the vaporometer and the corneometer in Experiment 7.
- FIG. 16b shows the R0 value by the cute meter in Experiment 7.
- * indicates that there is a significant difference from the value on the 0th day in Dunnett's test (***: p ⁇ 0.005, **: p ⁇ 0.01, *: p ⁇ 0. 05).
- FIG. 16c shows the results of subjective evaluation in Experiment 7. In FIG.
- FIG. 17 shows the setting of Experiment 8.
- the upper right of FIG. 17 shows an example (rectangular wave) of the waveform of the pressing stimulus of Experiment 8.
- the lower part of FIG. 17 shows the conditions of the pressing stimulus of Experiment 8 (waveform: Shape of wave, frequency: Frequency / Hz, depth: Displacement / ⁇ m, period: Day).
- FIG. 17 shows the conditions of the pressing stimulus of Experiment 8 (waveform: Shape of wave, frequency: Frequency / Hz, depth: Displacement / ⁇ m, period: Day).
- FIG. 18 shows a condition in which no pressing stimulus was applied to two skin samples (samples # 1 and # 2) obtained from a 44-year-old donor in Experiment 8 (Cont) and a condition in which a square wave pressing stimulus was applied (0.5 Hz / The localization of Ki67 (green) and nucleus (blue) on the 1st day (d1) and the 5th day (d5) at 100 ⁇ m) is shown.
- FIG. 19 shows one day under the conditions (Cont) in which a single pressing stimulus was not applied to the skin sample obtained from a 44-year-old donor in Experiment 8 and the conditions (square wave: 0.5 Hz, 5 Hz, 50 Hz / 100 ⁇ m).
- FIG. 21 shows the results of Experiment 9. In each figure, the left is the result when the pressing stimulus is applied (apply), and the right is the result when the pressing stimulus is not applied (control) on the 0th and 7th days. Is shown.
- FIG. 21a shows the measurement result by the corneometer.
- FIG. 21b shows the measurement result by the vapor meter.
- FIG. 21c shows the R0 value by the cute meter. In FIG. 21c, * indicates that there is a significant difference from the value on the 0th day in Dunnett's test (*: p ⁇ 0.05).
- the present inventors focused on the surface layer of the skin and conducted diligent research. As a result, it was discovered that the behavior of YAP in keratinocytes and the structure of actin fibers are related to aging. For example, when a physical stimulus such as extension was applied to the skin, the proportion of cells with nuclear-localized YAP and cells with actin stress fibers decreased significantly in aging keratinocytes. Furthermore, the present inventors searched for a new skin anti-aging agent and a method for skin anti-aging by using the behavior of YAP and the structure of actin fiber as an index of skin aging, and found a composition containing arabinoxylan.
- Skin anti-aging may be determined by measuring the ratio of the number of keratinized cells having nuclear localized YAP to the total number of keratinized cells.
- the presence or absence of nuclear localized YAP is determined by staining intracellular YAP, observing and imaging the endogenous YAP in the nucleus or cytoplasm with a microscope, and using image processing analysis software. It can be determined by quantifying the ratio of YAP to intracellular YAP by the degree of fluorescence intensity. Alternatively, it can be measured by the method described in Non-Patent Document 6 and Non-Patent Document 7.
- the ratio of the number of keratinized cells having nuclear localization YAP to the total number of keratinized cells is calculated by the above formula 2.
- the number of cells determined to have nuclear localization YAP by the above method is counted, and the cells whose nuclei are stained by nuclear staining such as DAPI or Hoechst33342 are counted as the total number of cells, and the formula 2 It may be calculated by.
- the nuclear localization of YAP is that the endogenous YAP in keratinocytes is localized in the nucleus as a transcriptional conjugating factor, with the increase or decrease in the total expression level remaining within a range of 2 times or less before and after the implementation.
- YAP is a Yes-associated protein, which is a protein of about 65 kDa, which is sometimes called YAP1, YAP65, or the like. It has been reported that YAP functions as a transcriptional regulator, is involved in cell proliferation and apoptosis, is associated with the maintenance and establishment of stem cells (nitch), and is associated with the development of tumors and cancers. YAP is degraded when it is present in the cytoplasm, but when it translocates into the nucleus, it is activated and regulates transcription. It has also been reported that such localization of YAP is associated with extracellular matrix hardness, cell density, cell proliferation and self-renewal (Non-Patent Documents 11 to 13).
- the skin anti-aging of the present invention may be determined using the presence or absence of actin stress fibers in keratinized cells as an index. For example, skin anti-aging may be determined by measuring the ratio of actin stress fiber-bearing keratinized cells to total keratinized cells. The presence or absence of actin stress fibers is determined by staining actin fibers with phalloidin cross-linked with a fluorescent compound and containing at least one actin stress fibers present in the cytoplasm or around the nucleus, as described in Examples. Can be determined to have.
- Non-Patent Document 9 it can be measured by the method described in Non-Patent Document 9 or Non-Patent Document 10.
- the ratio of the number of keratinized cells having actin stress fibers to the total number of keratinized cells is calculated by the above formula 3.
- the number of cells determined to have actin stress fibers by the method as described above may be counted, and the total number of cells may be counted by DAPI staining as described above and calculated by the formula 3.
- the keratinized cell having actin stress fiber refers to the keratinized cell in which actin stress fiber is formed without increasing the expression level of actin protein. This is because, as described in Non-Patent Document 8, the amount of actin protein does not change even if the presence or absence of YAP and the position of YAP (nucleus, cytoplasm, etc.) are different.
- the skin anti-aging of the present invention refers to, for example, a decrease in the ratio of the number of cells having nuclear-localized YAP or actin stress fibers to the total number of keratinized cells in the keratinized cells after applying a stretch stimulus to a skin sample. It may also mean suppression by the method / apparatus of the invention. Suppression is, for example, suppression of the decrease in the above percentage having a statistically significant difference (eg Student's t-test) with a significance level of 5%, and / or, for example, 10% or more, 20% or more, 30% or more, The suppression may be 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, or 100%.
- Non-Patent Document 11 Nuclear localization YAP and actin stress fibers are known to act indirectly or directly on cell proliferation and self-renewal.
- Non-Patent Document 12 Based on the findings of research on keratinocytes in the skin and various cell types, keratinocytes with phenomena such as YAP not being localized in the nucleus and actin stress fibers not being formed have low self-renewal ability and self-renewal ability.
- Non-Patent Document 13 Aging or differentiation-like cells have been suggested (Non-Patent Document 13).
- the number of aging keratinocytes having a weak nuclear localization YAP retention ability or a weak actin stress fiber forming ability was significantly reduced by the method / apparatus of the present invention. Therefore, although not bound by theory, the skin anti-aging agents and methods / devices of the present invention selectively eliminate the aging keratinocytes as described above, and have weak nuclear localized YAP retention ability or actin. It was suggested that the selection of "young" keratinocytes with retained stress fiber-forming ability and subsequent reactivation and cell proliferation were promoted.
- keratinocytes are proliferating or self-renewing. ..
- the skin anti-aging agent and method / device of the present invention selectively eliminate aging keratinocytes and select keratinocytes that proliferate and self-replicate, and as a result, proliferate and recover keratinocytes. It is possible that they are urging.
- a physical stimulus such as a stretch stimulus to the skin sample.
- the physical stimulus for measuring the degree of skin aging and the skin anti-aging effect may be the same as or different from the physical stimulus used in the anti-aging method / apparatus of the present invention, and the degree of skin aging is measured.
- Sufficient stimulation should be achieved.
- contact with skin samples such as living skin, post-collection skin, or cultured keratinocytes, such as tension, pressing, tapping, kneading, suction, and / or, for example, ultrasound, air pressure, or water pressure.
- the extension of the skin sample may be achieved by giving a physical stimulus by non-contact such as displacement by applying a shock wave to the skin, and the direction in which the physical stimulus is given is not limited.
- the present invention is a skin anti-aging agent comprising arabinoxylan as an active ingredient.
- skin anti-aging agents characterized by increasing cells with nuclear localized YAP and / or actin stress fibers that are reduced by physical stimulation in the skin.
- the arabinoxylan that can be used in the present invention is a kind of hemicellulose, which improves the elasticity of the skin, gives the skin suppleness, restores the ability of the skin to respond to physical stress, improves sagging and wrinkles, and the like.
- Is a known component Non-Patent Document 14
- arabinoxylan increases cells having nuclear-localized YAP and / or actin stress fibers, which are reduced by physical stimulation in the skin, and the present inventors have found for the first time. Is.
- the arabinoxylan that can be used in the present invention may be derived from rye (preferably rye seeds), and for example, an extract of rye seeds commercially available from Silab (trade name: Kohiris TM GR, or coheriss). (Registered trademark) (collectively referred to as "Kohiris” in the present specification)) may be derived.
- the agent of the present invention may be a composition in combination with other components of the above-mentioned active ingredients, such as excipients, carriers and / or diluents.
- the composition and form of the composition are arbitrary, and may be appropriately selected according to the conditions such as the active ingredient and the intended use.
- the composition can be produced by a conventional method with a formulation appropriately combined with an excipient, a carrier and / or a diluent and the like and other components according to the dosage form.
- the agent of the present invention can be blended in cosmetics or the like and used for humans and animals, or can be administered to humans and animals as a pharmaceutical preparation. In addition, it may be mixed with various foods and drinks and feeds and ingested by humans and animals.
- the blending amount thereof can be appropriately determined according to their types, purposes, forms, usage methods, and the like.
- the amount of Kohiris (trademark) GR is 0.00001% to 50% (v / v) (for example, 0.1 to 10%, preferably 1 to 1) in the total amount of cosmetics. 4% (v / v)) may be blended.
- ingredients usually used for skin external preparations such as cosmetics, pharmaceuticals, quasi-drugs, etc., such as antioxidants, oils, UV protective agents, within the range that does not impair the effects of the present invention.
- ingredients usually used for skin external preparations such as cosmetics, pharmaceuticals, quasi-drugs, etc., such as antioxidants, oils, UV protective agents, within the range that does not impair the effects of the present invention.
- Surfactants, thickeners, alcohols, powder components, coloring materials, aqueous components, water, various skin nutrients, etc. can be appropriately blended as needed.
- the external preparation for skin of the present invention can be applied as a cosmetic, a non-medicinal product, etc., which is applied to the outer skin, particularly preferably as a cosmetic, and the dosage form is not limited as long as it can be applied to the skin.
- Any formulation such as solution system, solubilization system, emulsification system, powder dispersion system, water-oil two-layer system, water-oil-powder three-layer system, ointment, lotion, gel, aerosol, etc. is applied.
- the agent of the present invention when used as cosmetics, it includes lotions, milky lotions, foundations, lipsticks, lip balms, cleansing creams, massage creams, packs, hand creams, hand powders, body shampoos, body lotions, body creams, bath cosmetics, etc. It may be used as a form.
- the possible forms of the agent and composition of the present invention are not limited to the above-mentioned dosage forms and forms.
- the invention is a cosmetic method for skin anti-aging that increases cells with nuclear localized YAP and / or actin stress fibers that are reduced by physical stimulation in the skin.
- the beauty method of the present invention in one embodiment provides a method including, in addition to the above step (a), a step of applying a weak physical stimulus to the skin. ..
- the present invention is an apparatus for skin anti-aging, which comprises a stimulus generating portion that generates a physical stimulus and a stimulating portion that imparts a physical stimulus generated in the stimulus generating portion to the skin, which can be applied to the above-mentioned beauty method. I will provide a.
- the step of applying a weak physical stimulus to the skin is to (b-1) stretch the skin to a stretch rate of 0.1% or more and 50.0% or less; and (c-1) from the stretched state.
- the cycle including recovery may be performed at a frequency of 60 Hz or less.
- the extension rate is calculated by the above formula 1. Physical stimulation is 0.001% or more and 80.0% or less, 0.01% or more and 60.0% or less, 0.1% or more and 50.0% or less, preferably 0.1% or more and 50.0% or less. It may be done at the extension rate.
- Extension speed refers to the speed (% / s) until the maximum extension rate (%) is reached in one cycle.
- the recovery rate refers to the rate (% / s) of returning from the maximum extension rate to the non-extension state.
- Extension speed / recovery speed is 0.010% / s to 40% / s, 0.05% / s to 30% / s, 0.10% / s to 20% / s, 0.2% / s to It may be carried out at any speed such as 15% / s and 0.3% / s to 10% / s.
- the extension rate and recovery rate may be the same or different.
- the step of applying a weak physical stimulus to the skin is (b-2) pressing the target skin by 1 ⁇ m to 1000 ⁇ m; and (c-2) recovering the target skin from the pressed state.
- the cycle including; may be performed at a frequency of 60 Hz or less.
- Pressing the skin from 1 ⁇ m to 1000 ⁇ m means pressing the skin to a depth of 1 ⁇ m to 1000 ⁇ m from the outermost surface of the skin.
- the depth of pressing can be arbitrarily set from 1 ⁇ m to 1000 ⁇ m, 10 ⁇ m to 1000 ⁇ m, 10 ⁇ m to 300 ⁇ m, 10 ⁇ m to 100 ⁇ m, etc. from the outermost surface of the skin.
- the frequency refers to the number of cycles per second when one cycle is the cycle of recovery from the start of extension or pressing to the non-extension or non-pressing state.
- One cycle may include maintaining a stretched or pressed state for a period of time and / or resting in a non-extended or non-pressed state.
- the frequency may be, for example, 0.0000001 Hz or more and 10 kHz or less, 0.000001 Hz or more and 1 kHz or less, 0.00001 Hz or more and 100 Hz or less, preferably 0.0001 Hz or more and 60 Hz or less, 0.0001 Hz or more and 10 Hz or less.
- facial equipment, massage equipment, etc. include those using electromagnetic waves having a frequency of about 0.3 to 300 MHz such as RF waves, and those using ultrasonic waves having a frequency of about 1 MHz to 7 MHz. Compared with these frequencies / frequencies, the frequencies adopted by the method / apparatus of the present invention are extremely low. If a strong frequency is applied to the skin like a conventional facial device, there is a risk of adverse effects such as redness, pressure marks, scratches, pain, and inflammation on the skin, but if a frequency like the present invention is adopted, the above risks Is low and allows non-invasive physical stimulation. This is because the present inventors have discovered that if the extension rate, the degree of pressing, the frequency, etc. are too high, the stimulation is too strong, and it is preferable to gently stimulate the skin by adjusting these values to appropriate values. ..
- low and medium frequency devices are commercially available as EMS devices, these are designed to act in deep layers such as muscle and subcutaneous fat, and the effect on the skin surface layer as in the present invention is unknown. .. Further, such a device may be accompanied by a tingling stimulus when an electric current is passed even if the frequency is low, which is different from the present invention that gives a gentle stimulus to the skin.
- the present invention enables a beauty method by a simple method of directly applying an extension or pressing stimulus to the skin without applying energy such as ultrasonic waves, electric current, or magnetic field. Further, the extension or pressing stimulus having such a frequency is a gentle stimulus, but has a good effect on both epidermal cells and dermis cells as described in Examples. Therefore, the use of the method / apparatus of the present invention is expected to have a cosmetic effect on the epidermis of the skin in the short term and on the dermis in the long term without adversely affecting the skin.
- the physical stimulus may be by an instrument such as a facial device, an experimental device, a massage using human hands or instruments, a facial exercise, or may be achieved by contact or non-contact. ..
- a mechanically generated physical stimulus is applied to the skin by using a device having a stimulus generating part that generates a physical stimulus and a stimulating part that applies the physical stimulus by contact or non-contact.
- Physical irritation may be achieved, for example, by contact such as pulling, pressing, tapping, kneading, sucking the skin, and / or displacement by applying a shock wave to the skin, for example, by ultrasonic waves or pneumatic pressure. It may be achieved by non-contact such as letting.
- Facial exercises include swelling the cheeks and opening the eyes. Examples of the massage include a massage using an instrument such as a hand or a roller by the subject to be treated or a practitioner such as a cosmetologist. However, it is not limited as long as it is within the range of the physical stimulus of the present invention.
- Examples of the device of the present invention include a beauty device provided with a skin contact portion that comes into contact with the user's skin and imparts the physical stimulus of the present invention.
- a beauty device provided with a skin contact portion that comes into contact with the user's skin and imparts the physical stimulus of the present invention.
- it may be composed of a grip portion and a skin extension portion or a skin pressing portion.
- the device shown on the left of FIG. 14 is designed to stretch the skin at a specific frequency and extension rate when the skin contact portion touches the skin.
- the device of the present invention includes a power supply, a stimulus generating part, and a skin stimulating part
- the power source generates an electric signal
- the stimulus generating part converts the electric signal from the power source into a physical stimulus.
- the skin stimulating part may receive the physical stimulus generated by the stimulating part and give the physical stimulus to the user's skin.
- the device shown on the left of FIG. 14 includes a grip portion, a power source, a control unit that controls physical stimulation, a stimulation generation unit, and a skin contact portion including a skin stimulation portion and a skin fixing portion.
- the user holds the grip part and puts the skin contact part on the skin, fixes the skin with the skin fixing part, and operates the control part so that the electrical signal from the power supply is physically stimulated by the stimulus generating part.
- the stimulus generator may be driven by a motor or the like to convert an electrical signal into a physical stimulus.
- the skin stimulating portion shown on the left side of FIG. 14 gives a stretching stimulus to the skin, but may, for example, give a pressing stimulus to the skin.
- the device of the present invention may be a cosmetological device including a power supply, a control unit for controlling physical stimulation, a stimulation generating unit, and a skin contact portion including a skin contact surface made of a sheet-like material. good.
- a skin contact portion of such a beauty device is shown on the right side of FIG.
- the sheet-like material can carry an electric current and may convert an electrical signal from a power source into a physical stimulus. Examples of such sheet-like materials include dielectric elastomer actuators (DEA), conductive polymers, IPMC, PVC gel, McCinnen type and the like.
- DEA dielectric elastomer actuators
- IPMC conductive polymers
- PVC gel McCinnen type and the like.
- the power source of the device of the present invention may be an internal power source or an external power source, or may be a rechargeable type. Further, the device of the present invention may, for example, use data stored in a mobile phone, cloud, or the like, or may be remotely operated wirelessly.
- the physical stimulus may be one that achieves the stretching or pressing of the skin by giving the physical stimulus by contact or non-contact as described above.
- the physical stimulus may be applied in the direction parallel to the skin surface, that is, in the lateral direction, in the direction perpendicular to the skin surface, that is, in the vertical direction, or in any direction such as an oblique direction or a twisting direction. can.
- the number of cycles to perform physical stimulation is not limited. For example, any number of cycles such as 2 to 500 cycles, 10 to 500 cycles, 20 to 400 cycles, 30 to 300 cycles, 40 to 200 cycles, and 50 to 100 cycles may be performed. For example, as described in Examples, 27 cycles may be sufficient.
- any number of these cycles may be regarded as one set, and this set may be performed with an arbitrary number of sets, for example, 1 to 100 sets, 2 to 50 sets, or 3 to 10 sets.
- the time to perform physical stimulation is not limited.
- the cycle may be repeated with or without a pause time for a certain period of time such as 5 minutes to 3 hours, 10 minutes to 2 hours, and 30 minutes to 1 hour.
- the time interval between cycles or sets is not limited.
- the extension or pressing stimulus may be one set or multiple sets alone, with one or more sets daily, 2, 3, 4, 5, 6, 6, and 7. It may be performed once, once every 1, 2, 3, or 4 weeks, etc., continuously or intermittently, regularly or irregularly.
- the frequency, extension rate, number of cycles, and frequency are not limited to those described above.
- the waveform for physical stimulation can be set arbitrarily, such as a square wave, sine wave, triangle wave, and sawtooth wave.
- the object to which the method of the present invention is applied may be an object in which skin aging is objectively or subjectively recognized, or an object in which skin aging is desired to be prevented.
- the subject may be judged to be deficient in skin constituents such as hyaluronic acid.
- the subject may be a subject judged to have a high degree of skin aging by using the behavior of YAP in the stratum corneum cells and / or the structure of actin fibers as an index.
- the ratio of the number of cells having nuclear localization YAP to the total number of keratinized cells and / or the ratio of the number of cells having actin stress fiber to the total number of keratinized cells was low. It may be a target. Alternatively, the subject may be concerned about skin aging, such as spots, wrinkles, sagging, dullness, conspicuous pores, or smoothness, elasticity, firmness, gloss, and decreased elasticity. Spots, wrinkles, sagging, dullness, conspicuous pores, smoothness, elasticity, firmness, luster, elasticity, etc. can be determined by using known indicators such as visual judgment, subjective or objective evaluation, and cute meter values. Can be decided.
- the skin anti-aging effect may mean an increase in the amount of hyaluronic acid in the dermis according to the present invention.
- the increase is, for example, an increase in hyaluronic acid having a statistically significant difference (eg, Student's t-test) with a significance level of 5%, and / or, for example, 10% or more, 20% or more, 30% or more, 40%.
- the increase may be 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 100% or more.
- the skin anti-aging effect may mean an increase in indicators such as skin viscoelasticity, elasticity, firmness, luster, smoothness, less noticeable pores, and less dullness according to the present invention.
- Skin viscoelasticity, elasticity, firmness, luster, smoothness, etc. can be measured by a cute meter or a subjective or objective index.
- the increase is, for example, an increase with a statistically significant difference (eg Dunnett's test or Wilcoxon signed rank test) with a significance level of 5%, and / or, for example, 10% or more, 20% or more, 30%.
- the increase may be 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 100% or more.
- the present invention can prevent and improve skin aging while exerting a favorable effect on a shallow layer such as the epidermis.
- a shallow layer such as the epidermis.
- to improve the behavior of YAP and the structure of actin fibers in keratinized cells especially for keratinized cells when a skin antiaging agent containing arabinoxylan as an active ingredient is applied to the skin or when physical stimulation is applied. It is possible to suppress the decrease in the proportion of cells having nuclear-localized YAP or actin stress fibers, or to recover the subsequent increase. In addition, it can lead to an increase in hyaluronic acid in the dermis, an increase in skin viscoelasticity and the above subjective or objective indicators.
- the present invention may be used in combination with other treatments.
- Other treatments include, but are not limited to, application of stimuli such as light stimulation, electrical stimulation, mechanical stimulation, human hand stimulation, administration of anti-aging agents, application of cosmetics, and the like.
- the anti-aging agent may be a naturally or chemically synthesized compound, an extract of animals and plants, a simple substance or a mixture, a state contained in a solvent such as an aqueous solution, cosmetics, etc. It may be in the form of.
- the administration route of the anti-aging agent can be arbitrarily selected, and examples thereof include oral administration, transdermal administration, subcutaneous administration, transmucosal administration, and intramuscular administration.
- the present invention may be aimed at beauty, medical treatment, stress relief, relaxation, and the like.
- the present invention is intended for cosmetology and may not be used by physicians or healthcare professionals.
- the present invention also provides a cosmetology counseling method that supports a cosmetological act of the subject, including presenting the present invention to the subject.
- Experiment 1 Changes in in vitro of keratinized cells due to aging Sample: Monolayer cultured keratinized cells from donors (0, 18, 44, 64 years old) of different ages purchased from KAC Co., Ltd. And fibroblast cultures were used.
- Stretching conditions Using ShellPa manufactured by Menicon Life Science, stretch stimulation was given to the above-mentioned keratinocytes and fibroblasts. The extension stimulation was performed at an extension rate of 10% as shown in the center of the lower figure of FIG. In the cycle, as shown on the left side of the upper figure of FIG. 1, the culture chamber was pulled in one direction at an extension rate of 0.33% / s, and the cells were extended to an extension rate of 10%. Then, the extended state was maintained for 5 minutes, and the cells were returned to the original non-extended state at a recovery rate of 0.33% / s. This was regarded as one cycle, and a total of 27 cycles were performed over 3 hours. The rest time between cycles was 0 to 10 seconds.
- YAP in cells uses anti-YAP antibody (Santa Cruz Biotechnology, YAP antibody (63.7): sc-10199), and actin fiber uses phalloidin (ThermoFisher Scientific, Alexa Fluor TM 488 P) cross-linked with a fluorescent compound.
- actin fiber uses phalloidin (ThermoFisher Scientific, Alexa Fluor TM 488 P) cross-linked with a fluorescent compound.
- YAP in cells uses anti-YAP antibody (Santa Cruz Biotechnology, YAP antibody (63.7): sc-10199)
- actin fiber uses phalloidin (ThermoFisher Scientific, Alexa Fluor TM 488 P) cross-linked with a fluorescent compound.
- YISS confocal laser scanning microscope
- ImageJ was used to quantify the nucleus-cytoplasm ratio of YAP by the degree of fluorescence intensity.
- the fluorescence intensity ratio between the nucleus and the cytoplasm was calculated, and the number of cells whose value was 1 ⁇ was counted as a cell having nuclear YAP.
- the total number of cells is stained using DAPI (Vector Laboratories, VECTASHIELD Mounting Medium with DAPI: H-1200), the number of cells stained with nuclei is counted, and the ratio of the number of cells having nuclear localized YAP is calculated. Calculated according to 2.
- cells containing at least one actin stress fiber in the cytoplasm or around the nucleus are counted as cells having actin stress fiber, the total number of cells is counted in the same manner, and the ratio of the number of cells having actin stress fiber is calculated by Equation 3. Calculated according to.
- FIGS. 2a and 2b Micrographs of keratinocytes are shown in FIGS. 2a and 2b.
- YAP is localized in the nucleus in almost all cells with and without extension stimulation.
- the number of cells having nuclear-localized YAP decreased sharply when extension stimulation was given.
- FIG. 3 shows the percentage of cells having nuclear localization YAP in keratinocytes. Although there was no change in the number of cells with nuclear localization YAP in the younger generation, it was significantly decreased in the keratinized cells in the elderly.
- FIG. 4 which shows the ratio of the number of cells having actin stress fibers in the keratinocytes
- FIG. 5 shows the ratio of the number of cells having actin stress fibers in the keratinocytes
- Experiment 2 Changes in ex vivo of keratinized cells due to aging
- Sample Ex vivo human abdominal skin tissue pieces (NativeSkin, 12well size, about 1 cm in diameter) obtained from Genoskin were used. The piece of tissue is 38 years old.
- Extension conditions A plastic pressing portion as shown in FIG. 6 was created. The bottom surface of the pressing portion was pressed vertically from the top of the sample so as to be pressed against the top surface of the sample, and the skin was adjusted to be stretched at an extension rate of 0.1% or less. Such a pressing motion is performed at a speed of 10% / s as shown in FIG.
- Observation method YAP and DAPI were stained, observed, and imaged in the same manner as in Experiment 1 under the conditions with and without extension stimulation.
- Experiment 3 Effect of in vitro on keratinocytes by extension stimulation
- Sample A monolayer culture of keratinocytes of the same middle-aged donor (44 years old) as in Experiment 1 was used.
- Extension conditions The same extension stimulus as in Experiment 1 was applied. That is, a set of 27 cycles of extension stimulation performed in Experiment 1 was given. However, 12 to 24 hours after giving one set of extension stimuli consisting of 27 cycles for 3 hours, the same extension stimulus was further given to the sample, and a total of two sets were performed.
- Observation method YAP after non-extension stimulation and extension stimulation was stained in the same manner as in Experiment 1.
- BrdU was stained with an anti-BrdU antibody (Abcam, Anti-BrdU antibody [BU1 / 75 (ICR1)]: ab6326) as a growth marker by the fluorescent antibody method.
- the treatment of BrdU was carried out for 6 hours, and 7 days later, it was fixed at 4 ° C. for 24 hours with 4% paraformaldehyde. The fixed sample was observed and imaged using a confocal laser scanning microscope (ZEISS, LSM700).
- the cell proliferation ability is restored or maintained similar to that of non-extended or young keratinocytes.
- the first extension stimulation promotes cell death of aging keratinocytes with low growth maintenance and self-renewal ability, or causes aging keratinocytes to peel off by some mechanism. It is considered that the proliferation and recovery of keratinocytes are promoted by selectively eliminating cells showing nuclear-localized YAP having high growth maintenance and self-renewal ability.
- Experiment 4 Effect of ex vivo on epidermis by extension stimulation
- Sample Ex vivo human abdominal skin tissue piece (NativeSkin, 6well size, about 2 to 2.5 cm in diameter) of a middle-aged donor (42 years old) purchased from Genoskin. used.
- Stretching conditions A stretching device having grips for gripping both ends of the skin in the well as shown in FIG. 10 and stretching the skin by pulling the grips was created.
- the well containing the above tissue piece was placed horizontally, and the grip portion was operated to stretch the skin from both ends, and as shown in FIG. 7, stretching with a stretching rate of 10% was performed at a rate of 10% / s.
- the sample was returned to its original non-extended state at a recovery rate of% / s.
- FIG. 11 shows the state of the non-extension stimulation on the 0th day and immediately after the extension stimulation (the 0th day).
- the number of epidermal cells in the basal layer having YAP decreased, and the proliferation marker Ki67 increased immediately after tension.
- FIG. 12 shows the state after culturing for 1 week after giving the extension stimulus twice for 2 consecutive days. Before extension, YAP was observed not only in the basal layer but also in the entire epidermal cells. YAP is usually abundant in the basal layer, but was observed in all layers of skin cultured for 1 week.
- cell aging may cause, for example, some abnormalities in cell proliferation and cell differentiation in each layer of the epidermis, resulting in altered YAP distribution.
- the expression distribution of YAP was maintained in the basal lamina after two stretching stimuli.
- physical stimulation activates and maintains homeostasis of cell proliferation and cell differentiation in the epidermis, resulting in a normal distribution of YAP in early fresh skin tissue even after 1 week of culture. It is also possible that the condition is maintained.
- Experiment 5 Effect of ex vivo on dermis by extension stimulation
- Sample and extension conditions Ex vivo human abdominal skin tissue piece (NativeSkin, 6well size, about diameter) of a middle-aged donor (44 years old) purchased from the same Genoskin company as in Experiment 4. 2 to 2.5 cm) was used. Three sets of extension stimulation, which is the same extension as in Experiment 4, was performed twice for two consecutive days.
- DAPI hyaluronic acid
- HOKUDO Biotin-HABP: BC41
- collagen Merck Millipore, Anti-human COL1N-terminal antibody: MAB1912
- DAPI hyaluronic acid
- ZEISS confocal laser scanning microscope
- Hyaluronic acid in the dermis was increased when the extension stimulus was given. It is shown that the extension stimulation not only promotes the proliferation of epidermal cells but also has a favorable effect on the dermis.
- Experiment 6 Effect of in vitro on keratinized cells by administration of Kohiris TM GR Sample: Using a monolayer culture of keratinized cells of the same middle-aged donor (44 years old) as in Experiment 1, 1 of the initiation of extension stimulation A day ago, Kohiris TM GR (water (84.50%), petylene glycol (10.00%), limegi seed extract (5.50%)) was added in 0.3% by volume and 1.0% by volume. Normal human keratinized cells were cultured for 1 day in a culture medium dissolved in a medium for exclusive use of keratinized cells (Epilife, Thermo Fisher Scientific, HuMedia-KG growth additive set, Kurabo).
- Experiment 7 Effect of in vivo by extension stimulation Subjects: 17 healthy women in their 30s and 50s were selected. Extension conditions: The extension device shown on the left side of FIG. 14 was used. In this device, the skin contact part indicated by the arrow on the left of FIG. 14 touches the skin, and the skin fixing part fixes the skin while appropriately setting the amount of vertical pushing of the skin extension part with respect to the skin within a range of a maximum of about 5 mm. It is designed to stretch the skin at a frequency of 1.2 Hz with a horizontal stretch rate of 0.1 to 20%. The subject applied this device to the half face to give a stretching stimulus for 30 minutes every day for 10 days.
- Measurement method On the 3rd and 10th days after the start of the experiment, the skin condition of each half face with and without stretching stimulation (treated) was measured.
- the skin condition is measured by measuring the percutaneous water evaporation (TEWL) with a vapor meter of Delfin Technologies, measuring the skin water with a Corneometer (CM825) of Course + Khazaka, and measuring the skin viscoelasticity with a cute meter (Courage + Khazaka). This was done by measuring with SEM575).
- the obtained data was statistically processed by comparing each with the value on the 0th day in Dunnett's test (***: p ⁇ 0.005, **: p ⁇ 0.01, *: p. ⁇ 0.05).
- the subjects made a subjective evaluation by entering the impressions of the cheeks before and 10 days after the extension stimulus on a 5-point scale for each of the following evaluation items.
- the results of the subjective evaluation were statistically processed by Wilcoxon signed rank test (***: p ⁇ 0.005, **: p ⁇ 0.01, *: p ⁇ 0.05).
- FIGS. 16a-c The results are shown in FIGS. 16a-c. As shown in FIG. 16a, neither TEWL nor the skin water content was changed by the extension stimulus, but as shown in FIG. 16b, the R0 value was significantly increased and the skin viscoelasticity was improved as measured by the cute meter. I found out that there is. This tendency was also seen in the R2 and R7 values. In addition, as shown in FIG. 16c, it was found that the subjects felt that the skin condition was improved in both the appearance and the tactile sensation.
- Experiment 8 Effect of ex vivo by pressing stimulus Sample: Ex vivo human abdominal skin tissue piece (NativeSkin, 6well size, about 2 to 2.5 cm in diameter) of a middle-aged donor (44 years old) purchased from the same Genoskin company as in Experiment 4. )It was used.
- Dielectric elastomer actuator manufactured by Sumitomo Riko Co., Ltd .: SRHP074-001
- the dielectric elastomer actuator is applied to the skin tissue piece and repeatedly contracted and expanded to press various waveforms of 0 to 100 ⁇ m under the conditions described in the lower part of FIG.
- the stimulus was given at a frequency of 0.5 Hz, 5 Hz, or 50 Hz for 1 or 5 days.
- Experiment 9 Effect of in vivo by pressing stimulus Subjects: 17 healthy women in their 30s and 50s were selected. Extension conditions: The pressing device shown in FIG. 20 and a dielectric elastomer actuator (manufactured by Sumitomo Riko Co., Ltd .: SRHP074-001) were used. In this device, the skin contact portion of the device shown in FIG. 20 pushes the skin with a force of 10 gf, so that the pressing stimulus of the rectangular wave shown in the lower part of FIG. 20 is given to the skin at a frequency of 5 Hz and a depth of 100 ⁇ m. Is designed for. As shown in FIG. 20, this device was applied to the medial part of the forearm of the subject, and the operation of applying a pressing stimulus for 30 minutes every day was performed for 5 days.
- Measurement method The skin condition of the medial part of the forearm with and without the pressing stimulus was measured before the start of the experiment and on the 7th day.
- the skin condition is measured by measuring the percutaneous water evaporation (TEWL) with a vapor meter of Delfin Technologies, measuring the skin water with a Corneometer (CM825) of Course + Khazaka, and measuring the skin viscoelasticity with a cute meter (Courage + Khazaka). This was done by measuring with SEM575).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Cosmetics (AREA)
Abstract
The present invention provides a skin anti-aging agent that includes arabinoxylan as an active ingredient, the skin anti-aging agent being characterized by increasing the number of cells having nuclear localized YAP that decreases upon receipt of physical stimulation on skin, and/or the number of cells having actin stress fibers. The present invention also provides: a beautification method that includes a step for applying, on the skin of a subject, the skin anti-aging agent containing arabinoxylan as an active ingredient; and a beautification instrument employed in the method.
Description
本発明は皮膚抗老化剤,皮膚抗老化のための美容方法,及びその方法に適用するための美容装置に関する。
The present invention relates to a skin anti-aging agent, a cosmetological method for skin anti-aging, and a cosmetological device for applying to the method.
皮膚老化は,加齢,ホルモン,代謝等の内部要因と,紫外線,乾燥等の外部要因を含め様々な因子が介在する皮膚の変化である。皮膚老化は,例えば,しみ,しわ,たるみ,しぼみなど外観から判断できる場合もあるが,例えば,皮膚内部組織の構造や構成成分の変化といった目に見えない老化が進行している場合もある。このような老化は気付かないうちに進行していることが多いため予防策をとりづらい。皮膚老化を予防・改善するための適切な対策をとることが重要である。
Skin aging is a change in the skin mediated by various factors including internal factors such as aging, hormones and metabolism, and external factors such as ultraviolet rays and dryness. Skin aging may be judged from the appearance such as spots, wrinkles, sagging, and deflation, but invisible aging such as changes in the structure and constituents of the internal tissues of the skin may be progressing. It is difficult to take preventive measures because such aging often progresses without being noticed. It is important to take appropriate measures to prevent and improve skin aging.
ここで,現在,種々な美容方法が存在する。例えば,特許文献1は,角質物質の変位を引き起こす電気活性材料アクチュエータを開示する。特許文献2は,皮膚を伸展させた状態で光照射を行う光照射美容器具を開示する。特許文献3は,皮下脂肪細胞を伸展させるストレッチと,脂肪蓄積抑制成分及び/又は脂肪細胞分化抑制成分を配合した皮膚外用剤を組み合わせた皮下脂肪を減少させる痩身方法を開示する。特許文献4は,カラス麦属植物の抽出物,又はオランダビユ属植物の抽出物を含有する伸展刺激介在コラーゲン分解酵素生成抑制剤を開示する。特許文献5は,伸展ストレスに起因するシワ改善剤又はNF-κB活性抑制剤を開示する。非特許文献1では,65~85Hzでの機械的刺激を推奨している。また,非特許文献1に記載の装置に関連する特許文献6では,約65~約120Hzといった周波数で皮膚を刺激する末端エフェクターを開示する。
Here, there are currently various beauty methods. For example, Patent Document 1 discloses an electroactive material actuator that causes displacement of a keratinous substance. Patent Document 2 discloses a light irradiation beauty device that irradiates light with the skin stretched. Patent Document 3 discloses a slimming method for reducing subcutaneous fat by combining a stretch that stretches subcutaneous adipocytes and an external skin preparation containing an adipocyte accumulation inhibitor and / or an adipocyte differentiation inhibitor. Patent Document 4 discloses an extension-stimulating-mediated collagen-degrading enzyme production inhibitor containing an extract of a plant of the genus Oat or an extract of a plant of the genus Psoralea. Patent Document 5 discloses a wrinkle improving agent or an NF-κB activity inhibitor caused by extension stress. Non-Patent Document 1 recommends mechanical stimulation at 65 to 85 Hz. Further, Patent Document 6 related to the apparatus described in Non-Patent Document 1 discloses a terminal effector that stimulates the skin at a frequency of about 65 to about 120 Hz.
しかし,皮膚表面より刺激を与える場合は表層部分である表皮にまず刺激が加わる為,表皮にダメージが加わるという問題がある。また,表皮直下には構造的に非常に特徴的な基底膜も存在し(アンジュレーション構造)機械刺激を受容する可能性が高いと考えられる。実際に先行文献によって物理刺激を与えることで表層が大きく変化することも報告されている(非特許文献2)。よって,表皮や基底膜を含めた皮膚に対し好ましい抗老化作用を奏する皮膚抗老化剤,方法および装置が求められる。
However, when stimulating from the skin surface, the stimulus is first applied to the epidermis, which is the surface layer, so there is a problem that the epidermis is damaged. In addition, there is also a structurally very characteristic basement membrane just below the epidermis (undulation structure), and it is highly likely that it will receive mechanical stimuli. It has also been reported that the surface layer is significantly changed by actually giving a physical stimulus according to the prior literature (Non-Patent Document 2). Therefore, there is a need for skin anti-aging agents, methods and devices that have a favorable anti-aging effect on the skin including the epidermis and basement membrane.
本発明の課題は,皮膚抗老化剤,皮膚抗老化のための美容方法およびその方法に適用するための美容装置の提供にある。
An object of the present invention is to provide a skin anti-aging agent, a cosmetological method for skin anti-aging, and a cosmetological device for applying to the method.
本発明者らは,鋭意研究の結果,アラビノキシランを含有する組成物を皮膚に与えた場合や,伸展などの物理刺激を特定の伸展率及び振動数で皮膚に与えた場合,皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させ,皮膚抗老化作用を奏することを発見し,本発明に想到した。
すなわち,本願は,以下の発明を提供する:
[1] アラビノキシランを有効成分として含む,皮膚抗老化剤であって、
皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させることを特徴とする、皮膚抗老化剤。
[2] 前記アラビノキシランが,ライムギ由来である,項目1に記載の皮膚抗老化剤。
[3] 前記アラビノキシランが,コヒリス(商標)GR由来である,項目1又は2に記載の皮膚抗老化剤。
[4] 皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させる,皮膚抗老化のための美容方法であって,
(a)対象の皮膚に,項目1~3のいずれか一項に記載の皮膚抗老化剤を適用すること,
を含む,美容方法。
[5] 前記美容方法は,さらに,前記皮膚に対して微弱な物理刺激を適用する工程を含み、ここで前記物理刺激を適用する工程は、例えば、
(b-1)前記対象の皮膚を0.1%以上50.0%以下の伸展率まで伸展することであって,ここで,伸展率は,
(式中,定点AおよびBは,表皮または表皮が接着しているマトリックス上の任意の位置であり,ここで定点AとBを通る直線が伸展方向と平行である)
で算出される;及び
(c-1)前記対象の皮膚を伸展状態から回復すること;
並びに/又は,
(b-2)前記対象の皮膚を,1μm~1000μm押圧すること;及び
(c-2)前記対象の皮膚を押圧状態から回復すること;
を含み,
ここで前記(b-1)及び(c-1)並びに/又は前記(b-2)及び(c-2)のサイクルが60Hz以下の振動数で実施される,
を含む,項目4に記載の美容方法。
[6] 前記サイクルを2~500サイクル行うセットを,1又は複数セット行う,項目5に記載の美容方法。
[7] 前記皮膚抗老化は,全角化細胞数に対する核局在YAPを有する細胞数の割合を指標として測定された場合,皮膚に前記美容方法を適用した後に伸展角化細胞で測定される核局在YAPを有する細胞数の割合が前記美容方法を適用する前と比べて増加することであり,ここで,核局在YAPを有する細胞数の割合は,
で算出される,項目4~6のいずれか一項に記載の美容方法。
[8] 前記皮膚抗老化は,全角化細胞数に対するアクチンストレスファイバーを有する細胞数の割合を指標として測定された場合,皮膚に前記美容方法を適用した後に伸展角化細胞で測定されるアクチンストレスファイバーを有する細胞数の割合が増加することであり,ここで,アクチンストレスファイバーを有する細胞数の割合は,
で算出される,項目4~6のいずれか一項に記載の美容方法。
[9] 項目5又は6に記載の美容方法に適用するための美容装置であって,
前記装置は,
物理刺激を生ずる刺激発生部と,
刺激発生部で発生した物理刺激を皮膚に付与する刺激付与部とを備え,
ここで,前記装置は,皮膚に対して微弱な物理刺激を適用する工程を行うための装置であり,ここで当該工程は,例えば,
(i-1)前記皮膚を0.1%以上50.0%以下の伸展率まで伸展すること;及び
(ii-1)前記皮膚を伸展状態から回復すること;
並びに/又は,
(i-2)前記皮膚を1μm~1000μm押圧すること;及び
(ii-2)前記皮膚を押圧状態から回復すること;を含むサイクルを60Hz以下の振動数で行うことであり,
ここで,伸展率は,上記式1により算出される,前記美容装置。
[10] 項目9に記載の美容装置を対象の皮膚に適用することを含む,皮膚抗老化のための美容方法。
[11]
皮膚におけるヒアルロン酸を増加するための,項目4~8及び10のいずれか1項に記載の美容方法。
[12] 項目1~3のいずれか1項に記載の皮膚抗老化剤,項目4~8及び10のいずれか1項に記載の美容方法又は項目9に記載の美容装置を対象に提示することを含む,対象の美容行為を支援する美容カウンセリング方法。 As a result of diligent research, the present inventors have conducted a physical stimulus on the skin when a composition containing arabinoxylan is applied to the skin or when a physical stimulus such as extension is applied to the skin at a specific extension rate and frequency. It was discovered that the number of cells having a decreasing nuclear localization YAP and / or a cell having an actin stress fiber is increased to exert a skin anti-aging effect, and the present invention was conceived.
That is, the present application provides the following inventions:
[1] A skin anti-aging agent containing arabinoxylan as an active ingredient.
A skin anti-aging agent characterized by increasing cells with nuclear localized YAP and / or actin stress fibers that are reduced by physical stimulation in the skin.
[2] The skin anti-aging agent according toitem 1, wherein the arabinoxylan is derived from rye.
[3] The skin anti-aging agent according to item 1 or 2, wherein the arabinoxylan is derived from Kohiris ™ GR.
[4] A cosmetic method for skin anti-aging that increases cells having nuclear-localized YAP and / or actin stress fibers that decrease due to physical stimulation in the skin.
(A) Applying the skin anti-aging agent according to any one ofitems 1 to 3 to the target skin,
Cosmetology methods, including.
[5] The cosmetological method further includes a step of applying a weak physical stimulus to the skin, wherein the step of applying the physical stimulus is, for example, for example.
(B-1) The target skin is stretched to a stretch rate of 0.1% or more and 50.0% or less, where the stretch rate is defined as.
(In the equation, the fixed points A and B are arbitrary positions on the epidermis or the matrix to which the epidermis is adhered, and the straight line passing through the fixed points A and B is parallel to the extension direction).
And (c-1) recovering the subject's skin from the stretched state;
And / or
(B-2) Pressing the subject's skin by 1 μm to 1000 μm; and (c-2) Recovering the subject's skin from the pressed state;
Including
Here, the cycles (b-1) and (c-1) and / or the cycles (b-2) and (c-2) are carried out at a frequency of 60 Hz or less.
4. The cosmetology method according toitem 4.
[6] The beauty method according toitem 5, wherein one or a plurality of sets are performed by performing the cycle for 2 to 500 cycles.
[7] When the skin anti-aging is measured using the ratio of the number of cells having nuclear localization YAP to the total number of keratinized cells as an index, the nucleus measured in the extended keratinized cells after applying the cosmetic method to the skin. The proportion of cells having localized YAP is increased as compared with before the application of the cosmetic method, and here, the proportion of cells having localized YAP is determined.
The beauty method according to any one of items 4 to 6, which is calculated in 1.
[8] When the skin anti-aging is measured using the ratio of the number of cells having actin stress fibers to the total number of keratinized cells as an index, actin stress measured in extended keratinized cells after applying the cosmetic method to the skin. The proportion of cells with fibers increases, where the proportion of cells with actin stress fibers is
The beauty method according to any one of items 4 to 6, which is calculated in 1.
[9] A cosmetological device for applying to the cosmetological method according toitem 5 or 6.
The device is
The stimulus generator that causes physical stimulus and
It is equipped with a stimulus-giving part that gives the physical stimulus generated in the stimulus-generating part to the skin.
Here, the device is a device for performing a step of applying a weak physical stimulus to the skin, and the step is described here, for example.
(I-1) Stretching the skin to a stretch rate of 0.1% or more and 50.0% or less; and (ii-1) Restoring the skin from the stretched state;
And / or
A cycle including (i-2) pressing the skin by 1 μm to 1000 μm; and (ii-2) recovering the skin from the pressed state; is performed at a frequency of 60 Hz or less.
Here, the extension rate is calculated by theabove formula 1, the beauty device.
[10] A cosmetological method for skin anti-aging, which comprises applying the cosmetological device according toitem 9 to the target skin.
[11]
The cosmetological method according to any one ofitems 4 to 8 and 10, for increasing hyaluronic acid in the skin.
[12] Presenting to the subject the skin anti-aging agent according to any one ofitems 1 to 3, the cosmetological method according to any one of items 4 to 8 and 10, or the cosmetological device according to item 9. Cosmetology counseling methods that support the subject's cosmetology, including.
すなわち,本願は,以下の発明を提供する:
[1] アラビノキシランを有効成分として含む,皮膚抗老化剤であって、
皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させることを特徴とする、皮膚抗老化剤。
[2] 前記アラビノキシランが,ライムギ由来である,項目1に記載の皮膚抗老化剤。
[3] 前記アラビノキシランが,コヒリス(商標)GR由来である,項目1又は2に記載の皮膚抗老化剤。
[4] 皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させる,皮膚抗老化のための美容方法であって,
(a)対象の皮膚に,項目1~3のいずれか一項に記載の皮膚抗老化剤を適用すること,
を含む,美容方法。
[5] 前記美容方法は,さらに,前記皮膚に対して微弱な物理刺激を適用する工程を含み、ここで前記物理刺激を適用する工程は、例えば、
(b-1)前記対象の皮膚を0.1%以上50.0%以下の伸展率まで伸展することであって,ここで,伸展率は,
で算出される;及び
(c-1)前記対象の皮膚を伸展状態から回復すること;
並びに/又は,
(b-2)前記対象の皮膚を,1μm~1000μm押圧すること;及び
(c-2)前記対象の皮膚を押圧状態から回復すること;
を含み,
ここで前記(b-1)及び(c-1)並びに/又は前記(b-2)及び(c-2)のサイクルが60Hz以下の振動数で実施される,
を含む,項目4に記載の美容方法。
[6] 前記サイクルを2~500サイクル行うセットを,1又は複数セット行う,項目5に記載の美容方法。
[7] 前記皮膚抗老化は,全角化細胞数に対する核局在YAPを有する細胞数の割合を指標として測定された場合,皮膚に前記美容方法を適用した後に伸展角化細胞で測定される核局在YAPを有する細胞数の割合が前記美容方法を適用する前と比べて増加することであり,ここで,核局在YAPを有する細胞数の割合は,
[8] 前記皮膚抗老化は,全角化細胞数に対するアクチンストレスファイバーを有する細胞数の割合を指標として測定された場合,皮膚に前記美容方法を適用した後に伸展角化細胞で測定されるアクチンストレスファイバーを有する細胞数の割合が増加することであり,ここで,アクチンストレスファイバーを有する細胞数の割合は,
[9] 項目5又は6に記載の美容方法に適用するための美容装置であって,
前記装置は,
物理刺激を生ずる刺激発生部と,
刺激発生部で発生した物理刺激を皮膚に付与する刺激付与部とを備え,
ここで,前記装置は,皮膚に対して微弱な物理刺激を適用する工程を行うための装置であり,ここで当該工程は,例えば,
(i-1)前記皮膚を0.1%以上50.0%以下の伸展率まで伸展すること;及び
(ii-1)前記皮膚を伸展状態から回復すること;
並びに/又は,
(i-2)前記皮膚を1μm~1000μm押圧すること;及び
(ii-2)前記皮膚を押圧状態から回復すること;を含むサイクルを60Hz以下の振動数で行うことであり,
ここで,伸展率は,上記式1により算出される,前記美容装置。
[10] 項目9に記載の美容装置を対象の皮膚に適用することを含む,皮膚抗老化のための美容方法。
[11]
皮膚におけるヒアルロン酸を増加するための,項目4~8及び10のいずれか1項に記載の美容方法。
[12] 項目1~3のいずれか1項に記載の皮膚抗老化剤,項目4~8及び10のいずれか1項に記載の美容方法又は項目9に記載の美容装置を対象に提示することを含む,対象の美容行為を支援する美容カウンセリング方法。 As a result of diligent research, the present inventors have conducted a physical stimulus on the skin when a composition containing arabinoxylan is applied to the skin or when a physical stimulus such as extension is applied to the skin at a specific extension rate and frequency. It was discovered that the number of cells having a decreasing nuclear localization YAP and / or a cell having an actin stress fiber is increased to exert a skin anti-aging effect, and the present invention was conceived.
That is, the present application provides the following inventions:
[1] A skin anti-aging agent containing arabinoxylan as an active ingredient.
A skin anti-aging agent characterized by increasing cells with nuclear localized YAP and / or actin stress fibers that are reduced by physical stimulation in the skin.
[2] The skin anti-aging agent according to
[3] The skin anti-aging agent according to
[4] A cosmetic method for skin anti-aging that increases cells having nuclear-localized YAP and / or actin stress fibers that decrease due to physical stimulation in the skin.
(A) Applying the skin anti-aging agent according to any one of
Cosmetology methods, including.
[5] The cosmetological method further includes a step of applying a weak physical stimulus to the skin, wherein the step of applying the physical stimulus is, for example, for example.
(B-1) The target skin is stretched to a stretch rate of 0.1% or more and 50.0% or less, where the stretch rate is defined as.
And (c-1) recovering the subject's skin from the stretched state;
And / or
(B-2) Pressing the subject's skin by 1 μm to 1000 μm; and (c-2) Recovering the subject's skin from the pressed state;
Including
Here, the cycles (b-1) and (c-1) and / or the cycles (b-2) and (c-2) are carried out at a frequency of 60 Hz or less.
4. The cosmetology method according to
[6] The beauty method according to
[7] When the skin anti-aging is measured using the ratio of the number of cells having nuclear localization YAP to the total number of keratinized cells as an index, the nucleus measured in the extended keratinized cells after applying the cosmetic method to the skin. The proportion of cells having localized YAP is increased as compared with before the application of the cosmetic method, and here, the proportion of cells having localized YAP is determined.
[8] When the skin anti-aging is measured using the ratio of the number of cells having actin stress fibers to the total number of keratinized cells as an index, actin stress measured in extended keratinized cells after applying the cosmetic method to the skin. The proportion of cells with fibers increases, where the proportion of cells with actin stress fibers is
[9] A cosmetological device for applying to the cosmetological method according to
The device is
The stimulus generator that causes physical stimulus and
It is equipped with a stimulus-giving part that gives the physical stimulus generated in the stimulus-generating part to the skin.
Here, the device is a device for performing a step of applying a weak physical stimulus to the skin, and the step is described here, for example.
(I-1) Stretching the skin to a stretch rate of 0.1% or more and 50.0% or less; and (ii-1) Restoring the skin from the stretched state;
And / or
A cycle including (i-2) pressing the skin by 1 μm to 1000 μm; and (ii-2) recovering the skin from the pressed state; is performed at a frequency of 60 Hz or less.
Here, the extension rate is calculated by the
[10] A cosmetological method for skin anti-aging, which comprises applying the cosmetological device according to
[11]
The cosmetological method according to any one of
[12] Presenting to the subject the skin anti-aging agent according to any one of
本発明によれば,皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させ,表皮といった浅い層に好ましい皮膚抗老化作用を奏する皮膚抗老化剤,美容方法およびその方法に使用するための美容装置が提供される。その結果,しみ,しわ,たるみといった皮膚老化の予防・改善が期待される。
According to the present invention, a skin anti-aging agent that increases cells having nuclear-localized YAP and / or cells having actin stress fibers, which are reduced by physical stimulation in the skin, and exerts a preferable skin anti-aging effect on a shallow layer such as the epidermis. Beauty methods and beauty devices for use in those methods are provided. As a result, prevention and improvement of skin aging such as age spots, wrinkles, and sagging are expected.
現在,真皮よりも深い層をターゲットとした美容方法は多く存在し,例えば,表情筋の強化,脂肪の分解促進,真皮線維の強化を目指すもの等が挙げられる。また,例えば特許文献1のように角質物質に着目した美容法も存在するものの電気的刺激によるものや,高い振動数を与える刺激の強いものが多い。しかしながら,上述のように皮膚表面より刺激を与えると,表皮にダメージが加わるという問題がある。さらには,特許文献4,5等に記載されるように伸展刺激は皮膚に対し悪影響を与えるという知見も存在し,実際,非特許文献2では,伸展刺激を与えることで表層が大きく変化することが報告されている。
Currently, there are many beauty methods that target layers deeper than the dermis, such as those that aim to strengthen facial muscles, promote fat decomposition, and strengthen dermis fibers. Further, for example, although there is a beauty method focusing on keratin substances as in Patent Document 1, there are many methods by electrical stimulation and strong stimulation that gives a high frequency. However, as described above, there is a problem that the epidermis is damaged when the skin is stimulated from the surface of the skin. Furthermore, as described in Patent Documents 4 and 5, there is a finding that the extension stimulus has an adverse effect on the skin. In fact, in Non-Patent Document 2, the surface layer is significantly changed by the extension stimulus. Has been reported.
ここで,本発明者らは,皮膚表層部に着目し鋭意研究を行った。その結果,角化細胞におけるYAPの挙動やアクチンファイバーの構造と老化が関連することを発見した。例えば,伸展などの物理刺激を皮膚に与えた場合,老化角化細胞では核局在YAPを有する細胞やアクチンストレスファイバーを有する細胞数の割合が著しく減少した。さらに,本発明者らは,YAPの挙動やアクチンファイバーの構造を皮膚老化の指標とし,新たな皮膚抗老化剤や,皮膚抗老化のための方法を探索したところ,アラビノキシランを含有する組成物を対象の皮膚に与えたり,特定の物理刺激を対象の皮膚に与えると,表皮を含む皮膚に好ましい効果が奏されることも発見した。より具体的には,老化した表皮であっても,アラビノキシランを有効成分として含む皮膚抗老化剤を適用することによって,老化角化細胞に特徴的な核局在YAP及び/又はアクチンストレスファイバーを有する細胞数の割合の減少を結果として抑制する効果が示唆された。また,老化した表皮であっても,微弱な物理刺激、例えば特定の伸展率で,例えば1Hz以下,10Hz以下といった60Hz以下の振動数で行う物理刺激を与えると,老化角化細胞に特徴的な核局在YAP及び/又はアクチンストレスファイバーを有する細胞数の割合の減少を結果として抑制する効果が示唆された。更には,このような物理刺激は,表皮のみならず真皮におけるヒアルロン酸量も増加することもわかり,皮膚老化の予防改善に有効であることが裏付けられた。
Here, the present inventors focused on the surface layer of the skin and conducted diligent research. As a result, it was discovered that the behavior of YAP in keratinocytes and the structure of actin fibers are related to aging. For example, when a physical stimulus such as extension was applied to the skin, the proportion of cells with nuclear-localized YAP and cells with actin stress fibers decreased significantly in aging keratinocytes. Furthermore, the present inventors searched for a new skin anti-aging agent and a method for skin anti-aging by using the behavior of YAP and the structure of actin fiber as an index of skin aging, and found a composition containing arabinoxylan. It was also found that when applied to the target skin or when a specific physical stimulus was applied to the target skin, a favorable effect was exerted on the skin including the epidermis. More specifically, even aged epidermis has nuclear-localized YAP and / or actin stress fibers characteristic of aging keratinocytes by applying a skin anti-aging agent containing arabinoxylan as an active ingredient. As a result, the effect of suppressing the decrease in the proportion of cell numbers was suggested. Even in the case of aged epidermis, when a weak physical stimulus is given, for example, a physical stimulus performed at a specific extension rate and a frequency of 60 Hz or less such as 1 Hz or less and 10 Hz or less, it is characteristic of aging keratinocytes. It was suggested that the effect of suppressing the decrease in the proportion of cells having nuclear-localized YAP and / or actin stress fibers was suggested. Furthermore, it was found that such physical stimulation increases the amount of hyaluronic acid not only in the epidermis but also in the dermis, demonstrating that it is effective in preventing and improving skin aging.
皮膚抗老化は,全角化細胞数に対する核局在YAPを有する角化細胞数の割合を測定することにより決定してもよい。核局在YAPの有無は,実施例に記載のように,細胞内のYAPを染色し,核又は細胞質にある内在性YAPを顕微鏡で観察,撮像し,画像処理解析ソフトウェアを使用して核内YAPと細胞質内YAPの比を蛍光強度の度合で数値化することにより決定できる。あるいは,非特許文献6や非特許文献7に記載の方法によっても測定できる。全角化細胞数に対する核局在YAPを有する角化細胞数の割合は,上記式2により算出される。例えば,上記のような方法で核局在YAPを有すると決定された細胞の数を計数し,例えばDAPIやHoechst33342等の核染色により核が染まった細胞を全細胞数として計数して,式2により算出してもよい。
Skin anti-aging may be determined by measuring the ratio of the number of keratinized cells having nuclear localized YAP to the total number of keratinized cells. The presence or absence of nuclear localized YAP is determined by staining intracellular YAP, observing and imaging the endogenous YAP in the nucleus or cytoplasm with a microscope, and using image processing analysis software. It can be determined by quantifying the ratio of YAP to intracellular YAP by the degree of fluorescence intensity. Alternatively, it can be measured by the method described in Non-Patent Document 6 and Non-Patent Document 7. The ratio of the number of keratinized cells having nuclear localization YAP to the total number of keratinized cells is calculated by the above formula 2. For example, the number of cells determined to have nuclear localization YAP by the above method is counted, and the cells whose nuclei are stained by nuclear staining such as DAPI or Hoechst33342 are counted as the total number of cells, and the formula 2 It may be calculated by.
1実施形態では,YAPの核局在は,角化細胞における内在性のYAPが,その全発現量の増減が実施前後で2倍以下の範囲にとどまり,転写共役因子として核に局在することを指す。非特許文献3~5から,YAPの阻害因子を欠失させ,YAPの核局在を促進させてもタンパク量レベルでの発現量の有意な亢進は起こらない(例えば,非特許文献5ではYAPのタンパク量は平均2倍以下である)ことが確認されているためである。
In one embodiment, the nuclear localization of YAP is that the endogenous YAP in keratinocytes is localized in the nucleus as a transcriptional conjugating factor, with the increase or decrease in the total expression level remaining within a range of 2 times or less before and after the implementation. Point to. From Non-Patent Documents 3 to 5, even if the inhibitor of YAP is deleted and the nuclear localization of YAP is promoted, the expression level is not significantly increased at the protein level (for example, in Non-Patent Document 5, YAP This is because it has been confirmed that the amount of protein in the above is less than twice on average).
YAPとは,Yes-associated proteinのことであり,YAP1,YAP65等と称されることもある約65kDaのタンパク質である。YAPは,転写調節因子として機能すること,細胞増殖やアポトーシス等に関与すること,幹細胞(ニッチ)の維持・確立,腫瘍や癌の発生と関連すること等が報告されている。YAPは,細胞質に存在すると分解されるが,核内に移行すると活性化し転写を調節する。このようなYAPの局在は,細胞外マトリックスの硬度,細胞密度,細胞増殖と自己複製等と関連することも報告されている(非特許文献11~13)。
YAP is a Yes-associated protein, which is a protein of about 65 kDa, which is sometimes called YAP1, YAP65, or the like. It has been reported that YAP functions as a transcriptional regulator, is involved in cell proliferation and apoptosis, is associated with the maintenance and establishment of stem cells (nitch), and is associated with the development of tumors and cancers. YAP is degraded when it is present in the cytoplasm, but when it translocates into the nucleus, it is activated and regulates transcription. It has also been reported that such localization of YAP is associated with extracellular matrix hardness, cell density, cell proliferation and self-renewal (Non-Patent Documents 11 to 13).
また,YAP上流因子であるアクチンの細胞質におけるストレスファイバー形成がYAP核局在に相関的かつ積極的に関与することが知られている。よって,本発明の皮膚抗老化は,角化細胞におけるアクチンストレスファイバーの有無を指標として決定してもよい。例えば,皮膚抗老化は,全角化細胞数に対するアクチンストレスファイバーを有する角化細胞数の割合を測定することにより決定してもよい。アクチンストレスファイバーの有無は,実施例に記載のように,アクチンファイバーを蛍光化合物を架橋したファロイジンにより染色し,細胞質中や核周辺に存在するアクチンストレスファイバーを1つでも含む場合,アクチンストレスファイバーを有するとして決定することができる。あるいは,非特許文献9や非特許文献10に記載の方法によっても測定できる。全角化細胞数に対するアクチンストレスファイバーを有する角化細胞数の割合は,上記式3により算出される。例えば,上記のような方法でアクチンストレスファイバーを有すると決定された細胞の数を計数し,例えば上述のようにDAPI染色により全細胞数を計数して,式3により算出してもよい。
It is also known that stress fiber formation in the cytoplasm of actin, which is an upstream factor of YAP, is correlated and actively involved in YAP nuclear localization. Therefore, the skin anti-aging of the present invention may be determined using the presence or absence of actin stress fibers in keratinized cells as an index. For example, skin anti-aging may be determined by measuring the ratio of actin stress fiber-bearing keratinized cells to total keratinized cells. The presence or absence of actin stress fibers is determined by staining actin fibers with phalloidin cross-linked with a fluorescent compound and containing at least one actin stress fibers present in the cytoplasm or around the nucleus, as described in Examples. Can be determined to have. Alternatively, it can be measured by the method described in Non-Patent Document 9 or Non-Patent Document 10. The ratio of the number of keratinized cells having actin stress fibers to the total number of keratinized cells is calculated by the above formula 3. For example, the number of cells determined to have actin stress fibers by the method as described above may be counted, and the total number of cells may be counted by DAPI staining as described above and calculated by the formula 3.
1実施形態では,アクチンストレスファイバーを有する角化細胞は,アクチンタンパク発現量の亢進を伴わずアクチンストレスファイバーが形成された角化細胞を指す。非特許文献8に記載のように,YAPの有無やYAPの存在位置(核,細胞質等)が異なっても,アクチンタンパク量の変動がないためである。
In one embodiment, the keratinized cell having actin stress fiber refers to the keratinized cell in which actin stress fiber is formed without increasing the expression level of actin protein. This is because, as described in Non-Patent Document 8, the amount of actin protein does not change even if the presence or absence of YAP and the position of YAP (nucleus, cytoplasm, etc.) are different.
したがって,本発明の皮膚抗老化とは,例えば,皮膚試料に伸展刺激を与えた後の角化細胞における全角化細胞数に対する核局在YAP又はアクチンストレスファイバーを有する細胞数の割合の低下を本発明の方法/装置により抑制するということを意味する場合もある。抑制は,例えば,有意水準を5%とした統計学的有意差(例えばスチューデントのt検定)を有する上記割合の低下の抑制,及び/又は,例えば10%以上,20%以上,30%以上,40%以上,50%以上,60%以上,70%以上,80%以上,90%以上,100%の抑制であってもよい。
Therefore, the skin anti-aging of the present invention refers to, for example, a decrease in the ratio of the number of cells having nuclear-localized YAP or actin stress fibers to the total number of keratinized cells in the keratinized cells after applying a stretch stimulus to a skin sample. It may also mean suppression by the method / apparatus of the invention. Suppression is, for example, suppression of the decrease in the above percentage having a statistically significant difference (eg Student's t-test) with a significance level of 5%, and / or, for example, 10% or more, 20% or more, 30% or more, The suppression may be 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, or 100%.
核局在YAPおよびアクチンストレスファイバーは,細胞増殖と自己複製に間接的又は直接的に働くことが知られている(非特許文献11)。一方,核外または細胞質に局在するYAP,細胞質にて分解するYAP,あるいはアクチンストレスファイバーの不形成は,細胞死や分化により細胞集団から排除される機構に関与することが明らかになってきている(非特許文献12)。皮膚の角化細胞および様々な細胞種における研究の知見から,YAPが核に局在しないことやアクチンストレスファイバーが形成されないといった現象を有する角化細胞は,自らの増殖維持や自己複製能の低い,老化又は分化様の細胞であることが示唆されている(非特許文献13)。また,本願実施例において,本発明の方法/装置により,核局在YAP保持能力の弱いあるいはアクチンストレスファイバー形成能力の弱い老化角化細胞の数が有意に減少した。したがって,理論に拘束されるものではないが,本発明の皮膚抗老化剤,方法/装置は,上記のような老化角化細胞を選択的に排除し,核局在YAP保持能力の弱いあるいはアクチンストレスファイバー形成能力の保持された“若い”角化細胞の選択とその後の再活性化,細胞増殖を促すことが示唆された。つまり,皮膚に本発明のアラビノキシランを含有する組成物を与えたり,さらに物理刺激を与えることにより,伸展した角化細胞において,YAPが核に局在しないまたはアクチンストレスファイバーが形成されていない角化細胞を選択的に排除し,YAPが核に局在する角化細胞やアクチンストレスファイバーを有する角化細胞を選択的に残す結果,角化細胞を増殖または自己複製させている可能性が考えられる。つまり,本発明の皮膚抗老化剤,方法/装置により,老化角化細胞を選択的に排除し,かつ増殖,自己複製する角化細胞を選択し,その結果,角化細胞の増殖や回復を促している可能性が考えられる。
Nuclear localization YAP and actin stress fibers are known to act indirectly or directly on cell proliferation and self-renewal (Non-Patent Document 11). On the other hand, it has become clear that the non-formation of YAP localized in the nucleus or cytoplasm, YAP degraded in the cytoplasm, or actin stress fiber is involved in the mechanism of exclusion from the cell population by cell death or differentiation. (Non-Patent Document 12). Based on the findings of research on keratinocytes in the skin and various cell types, keratinocytes with phenomena such as YAP not being localized in the nucleus and actin stress fibers not being formed have low self-renewal ability and self-renewal ability. , Aging or differentiation-like cells have been suggested (Non-Patent Document 13). In addition, in the examples of the present application, the number of aging keratinocytes having a weak nuclear localization YAP retention ability or a weak actin stress fiber forming ability was significantly reduced by the method / apparatus of the present invention. Therefore, although not bound by theory, the skin anti-aging agents and methods / devices of the present invention selectively eliminate the aging keratinocytes as described above, and have weak nuclear localized YAP retention ability or actin. It was suggested that the selection of "young" keratinocytes with retained stress fiber-forming ability and subsequent reactivation and cell proliferation were promoted. That is, keratinization in which YAP is not localized in the nucleus or actin stress fibers are not formed in the elongated keratinocytes by giving the composition containing the arabinoxylan of the present invention to the skin or further giving a physical stimulus. As a result of selectively eliminating cells and selectively leaving keratinocytes localized in the nucleus and keratinocytes having actin stress fibers, it is possible that keratinocytes are proliferating or self-renewing. .. That is, the skin anti-aging agent and method / device of the present invention selectively eliminate aging keratinocytes and select keratinocytes that proliferate and self-replicate, and as a result, proliferate and recover keratinocytes. It is possible that they are urging.
ここで,核局在YAP又はアクチンストレスファイバーを有する細胞数を測定する際に,皮膚試料に伸展刺激等の物理刺激を与えることが好ましい。皮膚老化度や皮膚抗老化作用を測定する際の物理刺激は,本発明の抗老化方法/装置で使用する物理刺激と同じであっても異なっていてもよく限定されず,皮膚老化度を測定するのに十分な刺激が達成されればよい。例えば,生体における皮膚,採取後の皮膚,又は培養角化細胞といった皮膚試料に対し,引張,押圧,叩く,揉む,吸引,といった接触,及び/又は,例えば,超音波や空気圧または水圧のようなもので皮膚に衝撃波をあたえることで変位させるといった非接触による物理的な刺激を与えることにより皮膚試料の伸展を達成するものであってもよく,物理刺激を与える方向も限定されない。
Here, when measuring the number of cells having nuclear-localized YAP or actin stress fibers, it is preferable to give a physical stimulus such as a stretch stimulus to the skin sample. The physical stimulus for measuring the degree of skin aging and the skin anti-aging effect may be the same as or different from the physical stimulus used in the anti-aging method / apparatus of the present invention, and the degree of skin aging is measured. Sufficient stimulation should be achieved. For example, contact with skin samples such as living skin, post-collection skin, or cultured keratinocytes, such as tension, pressing, tapping, kneading, suction, and / or, for example, ultrasound, air pressure, or water pressure. The extension of the skin sample may be achieved by giving a physical stimulus by non-contact such as displacement by applying a shock wave to the skin, and the direction in which the physical stimulus is given is not limited.
一実施態様において,本発明は,アラビノキシランを有効成分として含む,皮膚抗老化剤であって、
皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させることを特徴とする、皮膚抗老化剤を提供する。 In one embodiment, the present invention is a skin anti-aging agent comprising arabinoxylan as an active ingredient.
Provided are skin anti-aging agents characterized by increasing cells with nuclear localized YAP and / or actin stress fibers that are reduced by physical stimulation in the skin.
皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させることを特徴とする、皮膚抗老化剤を提供する。 In one embodiment, the present invention is a skin anti-aging agent comprising arabinoxylan as an active ingredient.
Provided are skin anti-aging agents characterized by increasing cells with nuclear localized YAP and / or actin stress fibers that are reduced by physical stimulation in the skin.
本発明において用いられる得るアラビノキシランは,ヘミセルロースの一種であり,肌の弾力改善や,肌にしなやかさを与えること,皮膚の物理的ストレスに対する応答能を回復すること,たるみやしわを改善することなどが知られている成分である(非特許文献14)。しかしながら,アラビノキシランが,皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させることについては,知られておらず,本願発明者らが初めて見出したことである。本発明において用いられる得るアラビノキシランは,ライムギ由来(好ましくは,ライムギ種子)であってもよく,例えば,Silab社より市販されているライムギ種子の抽出物(商品名:コヒリス(商標)GR,又はcoheliss(登録商標)(総称して,本明細書では「コヒリス」という。))に由来するものであってもよい。
The arabinoxylan that can be used in the present invention is a kind of hemicellulose, which improves the elasticity of the skin, gives the skin suppleness, restores the ability of the skin to respond to physical stress, improves sagging and wrinkles, and the like. Is a known component (Non-Patent Document 14). However, it is not known that arabinoxylan increases cells having nuclear-localized YAP and / or actin stress fibers, which are reduced by physical stimulation in the skin, and the present inventors have found for the first time. Is. The arabinoxylan that can be used in the present invention may be derived from rye (preferably rye seeds), and for example, an extract of rye seeds commercially available from Silab (trade name: Kohiris ™ GR, or coheriss). (Registered trademark) (collectively referred to as "Kohiris" in the present specification)) may be derived.
本発明の剤は,上記の有効成分の他の成分,例えば賦形剤,担体及び/又は希釈剤等と組み合わせた組成物とすることもできる。組成物の組成や形態は任意であり,有効成分や用途等の条件に応じて適切に選択すればよい。当該組成物は,その剤形に応じ,賦形剤,担体及び/又は希釈剤等及び他の成分と適宜組み合わせた処方で,常法を用いて製造することができる。
The agent of the present invention may be a composition in combination with other components of the above-mentioned active ingredients, such as excipients, carriers and / or diluents. The composition and form of the composition are arbitrary, and may be appropriately selected according to the conditions such as the active ingredient and the intended use. The composition can be produced by a conventional method with a formulation appropriately combined with an excipient, a carrier and / or a diluent and the like and other components according to the dosage form.
本発明の剤は,化粧品等に配合してヒト及び動物に使用し,或いは医薬製剤としてヒト及び動物に投与することができる。また,各種の飲食品,飼料に配合してヒト及び動物に摂取させてもよい。
The agent of the present invention can be blended in cosmetics or the like and used for humans and animals, or can be administered to humans and animals as a pharmaceutical preparation. In addition, it may be mixed with various foods and drinks and feeds and ingested by humans and animals.
本発明を化粧品,医薬品,医薬部外品等の皮膚外用剤に適用する場合,その配合量は,それらの種類,目的,形態,利用方法などに応じて,適宜決めることができる。例えば,コヒリス(商標)GRを用いた場合,化粧料全量中に,コヒリス(商標)GRが0.00001%~50%(v/v)(例えば,0.1~10%,好ましくは1~4%(v/v))配合されてもよい。
When the present invention is applied to external preparations for skin such as cosmetics, pharmaceuticals, and quasi-drugs, the blending amount thereof can be appropriately determined according to their types, purposes, forms, usage methods, and the like. For example, when Kohiris (trademark) GR is used, the amount of Kohiris (trademark) GR is 0.00001% to 50% (v / v) (for example, 0.1 to 10%, preferably 1 to 1) in the total amount of cosmetics. 4% (v / v)) may be blended.
上記成分に加えて,さらに必要により,本発明の効果を損なわない範囲内で,通常化粧品,医薬品,医薬部外品等の皮膚外用剤に用いられる成分,例えば酸化防止剤,油分,紫外線防御剤,界面活性剤,増粘剤,アルコール類,粉末成分,色材,水性成分,水,各種皮膚栄養剤等を必要に応じて適宜配合することができる。
In addition to the above ingredients, if necessary, ingredients usually used for skin external preparations such as cosmetics, pharmaceuticals, quasi-drugs, etc., such as antioxidants, oils, UV protective agents, within the range that does not impair the effects of the present invention. , Surfactants, thickeners, alcohols, powder components, coloring materials, aqueous components, water, various skin nutrients, etc. can be appropriately blended as needed.
本発明の皮膚外用剤は,外皮に適用される化粧料,医薬部外品等,特に好適には化粧料として適用可能であり,その剤型も皮膚に適用できるものであれば限定されず,溶液系,可溶化系,乳化系,粉末分散系,水-油二層系,水-油-粉末三層系,軟膏,化粧水,ゲル,エアゾール等,任意の剤型が適用される。
The external preparation for skin of the present invention can be applied as a cosmetic, a non-medicinal product, etc., which is applied to the outer skin, particularly preferably as a cosmetic, and the dosage form is not limited as long as it can be applied to the skin. Any formulation such as solution system, solubilization system, emulsification system, powder dispersion system, water-oil two-layer system, water-oil-powder three-layer system, ointment, lotion, gel, aerosol, etc. is applied.
本発明の剤を化粧品として用いる場合は,化粧水,乳液,ファンデーション,口紅,リップクリーム,クレンジングクリーム,マッサージクリーム,パック,ハンドクリーム,ハンドパウダー,ボディシャンプー,ボディローション,ボディクリーム,浴用化粧品等の形態として用いてもよい。
When the agent of the present invention is used as cosmetics, it includes lotions, milky lotions, foundations, lipsticks, lip balms, cleansing creams, massage creams, packs, hand creams, hand powders, body shampoos, body lotions, body creams, bath cosmetics, etc. It may be used as a form.
しかしながら,本発明の剤および組成物の採り得る形態は,上述の剤型や形態に限定されるものではない。
However, the possible forms of the agent and composition of the present invention are not limited to the above-mentioned dosage forms and forms.
他の態様において,本発明は,皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させる,皮膚抗老化のための美容方法であって,
(a)対象の皮膚に,アラビノキシランを有効成分として含む,上記の皮膚抗老化剤を適用すること,
を含む,美容方法を提供する。 In another aspect, the invention is a cosmetic method for skin anti-aging that increases cells with nuclear localized YAP and / or actin stress fibers that are reduced by physical stimulation in the skin.
(A) Applying the above-mentioned skin anti-aging agent containing arabinoxylan as an active ingredient to the target skin,
Provide beauty methods, including.
(a)対象の皮膚に,アラビノキシランを有効成分として含む,上記の皮膚抗老化剤を適用すること,
を含む,美容方法を提供する。 In another aspect, the invention is a cosmetic method for skin anti-aging that increases cells with nuclear localized YAP and / or actin stress fibers that are reduced by physical stimulation in the skin.
(A) Applying the above-mentioned skin anti-aging agent containing arabinoxylan as an active ingredient to the target skin,
Provide beauty methods, including.
一実施態様における本発明の美容方法は,上記工程(a)に加え,さらに,皮膚に対して微弱な物理刺激を適用する工程、を含む方法を提供する。。また,本発明は,上記の美容方法に適用され得る、物理刺激を生ずる刺激発生部と,刺激発生部で発生した物理刺激を皮膚に付与する刺激付与部とを備える皮膚抗老化のための装置を提供する。
The beauty method of the present invention in one embodiment provides a method including, in addition to the above step (a), a step of applying a weak physical stimulus to the skin. .. Further, the present invention is an apparatus for skin anti-aging, which comprises a stimulus generating portion that generates a physical stimulus and a stimulating portion that imparts a physical stimulus generated in the stimulus generating portion to the skin, which can be applied to the above-mentioned beauty method. I will provide a.
例えば,皮膚に対して微弱な物理刺激を適用する工程は,(b-1)皮膚を0.1%以上50.0%以下の伸展率まで伸展すること;及び(c-1)伸展状態から回復すること;を含むサイクルを60Hz以下の振動数で行うことであってもよい。
For example, the step of applying a weak physical stimulus to the skin is to (b-1) stretch the skin to a stretch rate of 0.1% or more and 50.0% or less; and (c-1) from the stretched state. The cycle including recovery; may be performed at a frequency of 60 Hz or less.
伸展率は,上記式1により算出される。物理刺激は,0.001%以上80.0以下,0.01%以上60.0%以下,0.1%以上50.0%以下,好ましくは,0.1%以上50.0%以下の伸展率で行ってもよい。例えば,0.1%以上1.0%以下,0.1%以上5.0%以下,0.1%以上10.0%以下,0.1%以上20.0%以下,0.1%以上30.0%以下,1.0%以上5.0%以下,1.0%以上10.0%以下,1.0%以上20.0%以下,1.0%以上30.0%以下,1.0%以上50.0%以下,10.0%以上20.0%以下,10.0%以上30.0%以下,等任意の範囲の伸展率が採用できる。
The extension rate is calculated by the above formula 1. Physical stimulation is 0.001% or more and 80.0% or less, 0.01% or more and 60.0% or less, 0.1% or more and 50.0% or less, preferably 0.1% or more and 50.0% or less. It may be done at the extension rate. For example, 0.1% or more and 1.0% or less, 0.1% or more and 5.0% or less, 0.1% or more and 10.0% or less, 0.1% or more and 20.0% or less, 0.1% 30.0% or less, 1.0% or more and 5.0% or less, 1.0% or more and 10.0% or less, 1.0% or more and 20.0% or less, 1.0% or more and 30.0% or less , 1.0% or more and 50.0% or less, 10.0% or more and 20.0% or less, 10.0% or more and 30.0% or less, and any range of extension rate can be adopted.
伸展速度は,1サイクル中で最大伸展率(%)に達するまでの速度(%/s)を指す。回復速度は,最大伸展率から非伸展状態に戻る速度(%/s)を指す。伸展速度・回復速度は,0.010%/s~40%/s,0.05%/s~30%/s,0.10%/s~20%/s,0.2%/s~15%/s,0.3%/s~10%/sなど任意の速度で行ってもよい。伸展速度と回復速度は同じでも異なっていてもよい。
Extension speed refers to the speed (% / s) until the maximum extension rate (%) is reached in one cycle. The recovery rate refers to the rate (% / s) of returning from the maximum extension rate to the non-extension state. Extension speed / recovery speed is 0.010% / s to 40% / s, 0.05% / s to 30% / s, 0.10% / s to 20% / s, 0.2% / s to It may be carried out at any speed such as 15% / s and 0.3% / s to 10% / s. The extension rate and recovery rate may be the same or different.
例えば,皮膚に対して微弱な物理刺激を適用する工程は,(b-2)前記対象の皮膚を1μm~1000μm押圧すること;及び(c-2)前記対象の皮膚を押圧状態から回復させること;を含むサイクルを60Hz以下の振動数で行うことであってもよい。
For example, the step of applying a weak physical stimulus to the skin is (b-2) pressing the target skin by 1 μm to 1000 μm; and (c-2) recovering the target skin from the pressed state. The cycle including; may be performed at a frequency of 60 Hz or less.
「皮膚を1μm~1000μm押圧する」とは,皮膚の最表面から1μm~1000μmの深度まで皮膚を押圧することを指す。押圧の深度は,皮膚の最表面から1μm~1000μm,10μm~1000μm,10μm~300μm,10μm~100μm等任意に設定可能である。
"Pressing the skin from 1 μm to 1000 μm" means pressing the skin to a depth of 1 μm to 1000 μm from the outermost surface of the skin. The depth of pressing can be arbitrarily set from 1 μm to 1000 μm, 10 μm to 1000 μm, 10 μm to 300 μm, 10 μm to 100 μm, etc. from the outermost surface of the skin.
振動数は,伸展又は押圧開始から非伸展又は非押圧状態まで回復するサイクルを1サイクルとした場合の1秒あたりのサイクル数を指す。1サイクルには,一定の時間,伸展又は押圧状態を維持すること及び/又は非伸展又は非押圧状態で休止することを含めてもよい。例えば,1サイクル中に(b-1)の後かつ(c-1)の前に,あるいは(b-2)の後かつ(c-2)の前に,0秒~30分間,1秒~20分間,5秒~10分間,又は10秒~5分間伸展又は押圧状態を保持すること;及び/又は(c-1)の後かつ次のサイクルの(b-1)の前に,あるいは(b-2)の後かつ(c-2)の前に,0秒~30秒間,0秒~20秒間,0秒~10秒間,1秒~10秒間,1秒~20秒間,1秒~10秒間非伸展又は非押圧状態で休止すること,を更に含んでもよい。振動数は,例えば,0.0000001Hz以上10kHz以下,0.000001Hz以上1kHz以下,0.00001Hz以上100Hz以下,好ましくは,0.0001Hz以上60Hz以下,0.0001Hz以上10Hz以下であってもよい。例えば,0.001Hz以上60Hz以下,0.01Hz以上60Hz以下,0.001Hz以上10Hz以下,0.01Hz以上10Hz以下,0.1Hz以上60Hz以下,0.1Hz以上10Hz以下,0.5Hz以上60Hz以下,0.5Hz以上50Hz以下,0.5Hz以上10Hz以下,0.5Hz以上5Hz以下,0.5Hz以上1Hz以下,0.001Hz以上0.01Hz以下,0.001Hz以上0.1Hz以下,0.001Hz以上1Hz以下,0.01Hz以上1Hz以下,0.1Hz以上1Hz以下,1Hz以上60Hz以下,1Hz以上10Hz以下,1Hz以上5Hz以下,等任意の範囲の振動数が採用できる。
The frequency refers to the number of cycles per second when one cycle is the cycle of recovery from the start of extension or pressing to the non-extension or non-pressing state. One cycle may include maintaining a stretched or pressed state for a period of time and / or resting in a non-extended or non-pressed state. For example, after (b-1) and before (c-1), or after (b-2) and before (c-2) in one cycle, 0 seconds to 30 minutes, 1 second to Hold the stretched or pressed state for 20 minutes, 5 seconds to 10 minutes, or 10 seconds to 5 minutes; and / or after (c-1) and before (b-1) of the next cycle, or ( After b-2) and before (c-2), 0 seconds to 30 seconds, 0 seconds to 20 seconds, 0 seconds to 10 seconds, 1 second to 10 seconds, 1 second to 20 seconds, 1 second to 10 It may further include resting in a non-extended or non-pressed state for a second. The frequency may be, for example, 0.0000001 Hz or more and 10 kHz or less, 0.000001 Hz or more and 1 kHz or less, 0.00001 Hz or more and 100 Hz or less, preferably 0.0001 Hz or more and 60 Hz or less, 0.0001 Hz or more and 10 Hz or less. For example, 0.001 Hz or more and 60 Hz or less, 0.01 Hz or more and 60 Hz or less, 0.001 Hz or more and 10 Hz or less, 0.01 Hz or more and 10 Hz or less, 0.1 Hz or more and 60 Hz or less, 0.1 Hz or more and 10 Hz or less, 0.5 Hz or more and 60 Hz or less. , 0.5Hz or more and 50Hz or less, 0.5Hz or more and 10Hz or less, 0.5Hz or more and 5Hz or less, 0.5Hz or more and 1Hz or less, 0.001Hz or more and 0.01Hz or less, 0.001Hz or more and 0.1Hz or less, 0.001Hz Frequencies in any range such as 1 Hz or less, 0.01 Hz or more and 1 Hz or less, 0.1 Hz or more and 1 Hz or less, 1 Hz or more and 60 Hz or less, 1 Hz or more and 10 Hz or less, 1 Hz or more and 5 Hz or less can be adopted.
市販の美顔器,マッサージ機器等には,RF波といった0.3~300MHz程度の周波数を有する電磁波を用いるものや,1MHzから7MHz程度の周波数を有する超音波を用いるものなどがある。これらの周波数/振動数と比べ,本発明の方法/装置が採用する振動数は極めて低い。従来の美顔器等のように皮膚に強い振動数を与えると皮膚に赤み,圧力痕,傷,痛み,炎症といった悪影響を与えるリスクがあるが,本発明のような振動数を採用すると上述のリスクが低く非侵襲的な物理刺激が可能になる。本発明者らにより,伸展率,押圧度,振動数等が高すぎると刺激が強すぎるため,これらの値を適正値に調節することにより皮膚を優しく刺激するほうが好ましいことが発見されたためである。
Commercially available facial equipment, massage equipment, etc. include those using electromagnetic waves having a frequency of about 0.3 to 300 MHz such as RF waves, and those using ultrasonic waves having a frequency of about 1 MHz to 7 MHz. Compared with these frequencies / frequencies, the frequencies adopted by the method / apparatus of the present invention are extremely low. If a strong frequency is applied to the skin like a conventional facial device, there is a risk of adverse effects such as redness, pressure marks, scratches, pain, and inflammation on the skin, but if a frequency like the present invention is adopted, the above risks Is low and allows non-invasive physical stimulation. This is because the present inventors have discovered that if the extension rate, the degree of pressing, the frequency, etc. are too high, the stimulation is too strong, and it is preferable to gently stimulate the skin by adjusting these values to appropriate values. ..
また,従来,当該分野において一般的に利用されているモーター等の機構を利用する美容機器類ではそのモーターの機械的機構から60Hzを超える振動数しか選択できないことが当業者の技術常識であった。従来技術における美容機器類の限界である「60Hz」以下の振動数,例えば,60Hz以下,10Hz以下,1Hz以下といった本発明のような振動数を採用するには,特別な機械を作成する必要性が求められていた。更には,このような低い振動数では,本発明の効果を奏するには「弱すぎる」という固定概念もあり,これまで検討がほとんどされていなかった。しかしながら,本発明者らは,従来の技術常識から考えると非常に低い振動数を用いて実際に皮膚に物理刺激を与えてみたところ,驚くべきことに,このような低い振動数の優しい刺激でも良好な効果が奏された。
In addition, it has been a common general knowledge of those skilled in the art that in beauty equipment that uses a mechanism such as a motor that is generally used in the field, only a frequency exceeding 60 Hz can be selected from the mechanical mechanism of the motor. .. In order to adopt a frequency of "60 Hz" or less, which is the limit of beauty equipment in the prior art, for example, a frequency of 60 Hz or less, 10 Hz or less, 1 Hz or less as in the present invention, it is necessary to create a special machine. Was required. Furthermore, there is a fixed concept that such a low frequency is "too weak" to achieve the effect of the present invention, and so far, little study has been made. However, when the present inventors actually applied a physical stimulus to the skin using a very low frequency considering the conventional common sense of technology, surprisingly, even with such a gentle stimulus with a low frequency, the present inventors tried to give a physical stimulus to the skin. A good effect was achieved.
EMS機器等では低中周波の装置も市販されているものの,これらは特に筋肉や皮下脂肪等の深い層で作用させるように設計されており,本願発明のような皮膚表層に対する影響は不明である。また,このような装置は周波数が低くても電流を流す際にビリビリとした刺激を伴うこともあり,皮膚に優しい刺激を与える本願発明とは異なる。一方,本発明は,超音波や電流,磁場といったエネルギーを加えず,直接皮膚に伸展又は押圧刺激を与えるという簡便な方法による美容法が可能である。更に,このような振動数を有する伸展又は押圧刺激は,優しい刺激でありながら,実施例に記載のように表皮細胞にも真皮細胞にも良好な効果を奏する。よって,本発明の方法/装置を使用すると,皮膚に悪影響を与えず,短期的には皮膚の表皮に,長期的には真皮に美容効果が期待される。
Although low and medium frequency devices are commercially available as EMS devices, these are designed to act in deep layers such as muscle and subcutaneous fat, and the effect on the skin surface layer as in the present invention is unknown. .. Further, such a device may be accompanied by a tingling stimulus when an electric current is passed even if the frequency is low, which is different from the present invention that gives a gentle stimulus to the skin. On the other hand, the present invention enables a beauty method by a simple method of directly applying an extension or pressing stimulus to the skin without applying energy such as ultrasonic waves, electric current, or magnetic field. Further, the extension or pressing stimulus having such a frequency is a gentle stimulus, but has a good effect on both epidermal cells and dermis cells as described in Examples. Therefore, the use of the method / apparatus of the present invention is expected to have a cosmetic effect on the epidermis of the skin in the short term and on the dermis in the long term without adversely affecting the skin.
物理刺激は,美顔器などの器具,実験的な装置,ヒトの手や器具を用いたマッサージ,顔面のエクササイズによるものであってもよく,接触又は非接触により達成されるものであってもよい。一態様では,物理刺激を生ずる刺激発生部と,物理刺激を接触又は非接触により付与する刺激付与部を備えた機器を用いて,皮膚に対して機械的に発生された物理刺激を付与することができる。物理刺激は,例えば,皮膚を引張,押圧,叩く,揉む,吸引するといった接触によって達成されてもよく,及び/又は,例えば,超音波や空気圧のようなもので皮膚に衝撃波をあたえることで変位させるといった非接触により達成されてもよい。顔面のエクササイズとしては,頬を膨らませることや,目を見開くことなどが行うことができる。マッサージとしては,施術を受ける対象自身又は美容部員などの施術者による手やローラー等の器具を用いたマッサージが挙げられる。しかしながら,本発明の物理刺激の範囲内であれば限定されない。
The physical stimulus may be by an instrument such as a facial device, an experimental device, a massage using human hands or instruments, a facial exercise, or may be achieved by contact or non-contact. .. In one aspect, a mechanically generated physical stimulus is applied to the skin by using a device having a stimulus generating part that generates a physical stimulus and a stimulating part that applies the physical stimulus by contact or non-contact. Can be done. Physical irritation may be achieved, for example, by contact such as pulling, pressing, tapping, kneading, sucking the skin, and / or displacement by applying a shock wave to the skin, for example, by ultrasonic waves or pneumatic pressure. It may be achieved by non-contact such as letting. Facial exercises include swelling the cheeks and opening the eyes. Examples of the massage include a massage using an instrument such as a hand or a roller by the subject to be treated or a practitioner such as a cosmetologist. However, it is not limited as long as it is within the range of the physical stimulus of the present invention.
本発明の装置として,例えば,使用者の皮膚に接触し本発明の物理刺激を付与する皮膚接触部を備える美容装置が挙げられる。例えば,把持部及び皮膚伸展部又は皮膚押圧部から構成されるものであってもよい。例えば,図14左に記載の装置は,皮膚接触部が皮膚に触れることにより,皮膚を特定の振動数および伸展率にて伸展するように設計されている。
Examples of the device of the present invention include a beauty device provided with a skin contact portion that comes into contact with the user's skin and imparts the physical stimulus of the present invention. For example, it may be composed of a grip portion and a skin extension portion or a skin pressing portion. For example, the device shown on the left of FIG. 14 is designed to stretch the skin at a specific frequency and extension rate when the skin contact portion touches the skin.
また,例えば,本発明の装置は,電源と,刺激発生部と,皮膚刺激部を備え,電源は電気信号を発生し,刺激発生部は,電源からの電気信号を物理的な刺激に変換して物理刺激を発生し,皮膚刺激部は,刺激発生部で発生された物理刺激を受け取り使用者の皮膚に物理刺激を与えるものであってもよい。
Further, for example, the device of the present invention includes a power supply, a stimulus generating part, and a skin stimulating part, the power source generates an electric signal, and the stimulus generating part converts the electric signal from the power source into a physical stimulus. The skin stimulating part may receive the physical stimulus generated by the stimulating part and give the physical stimulus to the user's skin.
例えば,図14左に示す装置は,把持部と,電源と,物理的な刺激を制御する制御部と,刺激発生部と,皮膚刺激部と皮膚固定部を含む皮膚接触部とを備える。使用者が把持部を持って皮膚接触部を皮膚に当て,皮膚固定部により皮膚を固定するようにし,制御部を操作することにより電源からの電気的な信号が刺激発生部により物理的な刺激に変換され,物理刺激が皮膚刺激部に伝わり,皮膚が皮膚固定部に固定されつつ皮膚刺激部により特定の振動数および伸展率にて伸展されるように設計されている。例えば,刺激発生部はモーターなどにより駆動され電気信号を物理刺激に変換するものであってもよい。また,図14左に記載の皮膚刺激部は,皮膚に伸展刺激を与えるものであるが,例えば,皮膚に押圧刺激を与えるものであってもよい。
For example, the device shown on the left of FIG. 14 includes a grip portion, a power source, a control unit that controls physical stimulation, a stimulation generation unit, and a skin contact portion including a skin stimulation portion and a skin fixing portion. The user holds the grip part and puts the skin contact part on the skin, fixes the skin with the skin fixing part, and operates the control part so that the electrical signal from the power supply is physically stimulated by the stimulus generating part. It is designed so that the physical stimulus is transmitted to the skin stimulating part, and the skin is stretched at a specific frequency and extension rate by the skin stimulating part while being fixed to the skin fixing part. For example, the stimulus generator may be driven by a motor or the like to convert an electrical signal into a physical stimulus. The skin stimulating portion shown on the left side of FIG. 14 gives a stretching stimulus to the skin, but may, for example, give a pressing stimulus to the skin.
あるいは,本発明の装置は,電源と,物理的な刺激を制御する制御部と,刺激発生部と,シート状の材料からなる皮膚接触面を含む皮膚接触部とを備える美容装置であってもよい。例として,図14右にこのような美容装置の皮膚接触部を示す。シート状の材料は,電流を流すことが可能で,電源からの電気的な信号を物理的な刺激に変換するものであってもよい。そのようなシート状の材料としては,誘電エラストマーアクチュエータ(DEA),導電ポリマー,IPMC,PVCゲル,Mckinnen型などが挙げられる。
Alternatively, the device of the present invention may be a cosmetological device including a power supply, a control unit for controlling physical stimulation, a stimulation generating unit, and a skin contact portion including a skin contact surface made of a sheet-like material. good. As an example, the skin contact portion of such a beauty device is shown on the right side of FIG. The sheet-like material can carry an electric current and may convert an electrical signal from a power source into a physical stimulus. Examples of such sheet-like materials include dielectric elastomer actuators (DEA), conductive polymers, IPMC, PVC gel, McCinnen type and the like.
本発明の装置の電源は,内部電源又は外部電源であってもよく,充電式であってもよい。また,本発明の装置は,例えば,携帯電話やクラウドなどに保存されているデータを用いるものであっても,ワイヤレスでリモート操作されるものであってもよい。
The power source of the device of the present invention may be an internal power source or an external power source, or may be a rechargeable type. Further, the device of the present invention may, for example, use data stored in a mobile phone, cloud, or the like, or may be remotely operated wirelessly.
物理刺激は,上述のような接触又は非接触による物理的な刺激を与えることにより皮膚の伸展又は押圧を達成するものであってもよい。物理刺激は,皮膚表面に対し平行方向,すなわち横方向に加えてもよいし,皮膚表面に対し垂直方向,すなわち縦方向に加えてもよいし,あるいは斜め方向,ねじれ方向等任意の方向が採用できる。
The physical stimulus may be one that achieves the stretching or pressing of the skin by giving the physical stimulus by contact or non-contact as described above. The physical stimulus may be applied in the direction parallel to the skin surface, that is, in the lateral direction, in the direction perpendicular to the skin surface, that is, in the vertical direction, or in any direction such as an oblique direction or a twisting direction. can.
物理刺激を行うサイクル数は限定されない。例えば,2~500サイクル,10~500サイクル,20~400サイクル,30~300サイクル,40~200サイクル,50~100サイクルといった任意の数のサイクル行なってもよい。例えば,実施例に記載のように,27サイクル行えば十分な場合もある。
The number of cycles to perform physical stimulation is not limited. For example, any number of cycles such as 2 to 500 cycles, 10 to 500 cycles, 20 to 400 cycles, 30 to 300 cycles, 40 to 200 cycles, and 50 to 100 cycles may be performed. For example, as described in Examples, 27 cycles may be sufficient.
さらに,これらの任意の数のサイクルを1セットとし,このセットを任意の数のセット,例えば,1~100セット,2~50セット,又は3~10セット行ってもよい。
Further, any number of these cycles may be regarded as one set, and this set may be performed with an arbitrary number of sets, for example, 1 to 100 sets, 2 to 50 sets, or 3 to 10 sets.
物理刺激を行う時間も限定されない。例えば,休止時間を設けて又は設けずにサイクルを繰り返し5分~3時間,10分~2時間,30分~1時間といった一定時間行ってもよい。
The time to perform physical stimulation is not limited. For example, the cycle may be repeated with or without a pause time for a certain period of time such as 5 minutes to 3 hours, 10 minutes to 2 hours, and 30 minutes to 1 hour.
サイクル間又はセット間の時間間隔も限定されない。例えば,伸展又は押圧刺激は,1セット又は複数セットを単独で行うものであってもよく,1又は複数のセットを毎日,2日,3日,4日,5日,6日,7日に1回,1,2,3,4週間に1回等,連続的又は断続的に定期的又は不定期的に行うものであってもよい。
The time interval between cycles or sets is not limited. For example, the extension or pressing stimulus may be one set or multiple sets alone, with one or more sets daily, 2, 3, 4, 5, 6, 6, and 7. It may be performed once, once every 1, 2, 3, or 4 weeks, etc., continuously or intermittently, regularly or irregularly.
しかしながら,皮膚抗老化作用を発揮するのに十分な刺激が達成されれば上記のような振動数,伸展率,サイクル数,頻度に限定されない。物理刺激を行う波形も,矩形波,正弦波,三角波,のこぎり波等任意に設定できる。
However, if sufficient stimulation is achieved to exert the skin anti-aging effect, the frequency, extension rate, number of cycles, and frequency are not limited to those described above. The waveform for physical stimulation can be set arbitrarily, such as a square wave, sine wave, triangle wave, and sawtooth wave.
本発明の方法を適用する対象は,皮膚老化が客観的又は主観的に認められる対象であっても,皮膚老化を予防したいと希望する対象であってもよい。例えば,ヒアルロン酸などの皮膚構成成分が不足していると判断された対象であってもよい。1実施形態では,角層細胞におけるYAPの挙動及び/又はアクチンファイバーの構造を指標として皮膚老化度が高いと判断された対象であってもよい。例えば,伸展角化細胞で測定した場合,全角化細胞数に対する核局在YAPを有する細胞数の割合,及び/又は全角化細胞数に対するアクチンストレスファイバーを有する細胞数の割合が低いと判断された対象であってもよい。あるいは,皮膚の老化,例えば,しみ,しわ,たるみ,くすみ,毛穴の目立ち,あるいは,なめらかさ,はり,ハリ感,つや,弾力の低下等が気になる対象であってもよい。しみ,しわ,たるみ,くすみ,毛穴の目立ち,なめらかさ,はり,ハリ感,つや,弾力等は,視感判定,主観的又は客観的な評価,キュートメーターの値など公知の指標を用いることにより決定することができる。
The object to which the method of the present invention is applied may be an object in which skin aging is objectively or subjectively recognized, or an object in which skin aging is desired to be prevented. For example, the subject may be judged to be deficient in skin constituents such as hyaluronic acid. In one embodiment, the subject may be a subject judged to have a high degree of skin aging by using the behavior of YAP in the stratum corneum cells and / or the structure of actin fibers as an index. For example, when measured with stretched keratinized cells, it was determined that the ratio of the number of cells having nuclear localization YAP to the total number of keratinized cells and / or the ratio of the number of cells having actin stress fiber to the total number of keratinized cells was low. It may be a target. Alternatively, the subject may be concerned about skin aging, such as spots, wrinkles, sagging, dullness, conspicuous pores, or smoothness, elasticity, firmness, gloss, and decreased elasticity. Spots, wrinkles, sagging, dullness, conspicuous pores, smoothness, elasticity, firmness, luster, elasticity, etc. can be determined by using known indicators such as visual judgment, subjective or objective evaluation, and cute meter values. Can be decided.
代替的及び/又は追加的に,皮膚抗老化作用は,本発明による真皮におけるヒアルロン酸量の増加を意味する場合もある。増加は,例えば,有意水準を5%とした統計学的有意差(例えばスチューデントのt検定)を有するヒアルロン酸の増加,及び/又は,例えば10%以上,20%以上,30%以上,40%以上,50%以上,60%以上,70%以上,80%以上,90%以上,100%以上の増加であってもよい。
Alternatively and / or additionally, the skin anti-aging effect may mean an increase in the amount of hyaluronic acid in the dermis according to the present invention. The increase is, for example, an increase in hyaluronic acid having a statistically significant difference (eg, Student's t-test) with a significance level of 5%, and / or, for example, 10% or more, 20% or more, 30% or more, 40%. The increase may be 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 100% or more.
代替的及び/又は追加的に,皮膚抗老化作用は,本発明による,皮膚粘弾性,はり,ハリ感,つや,なめらかさ,毛穴の目立たなさ,くすみのなさといった指標の増加を意味する場合もある。皮膚粘弾性,はり,ハリ感,つや,なめらかさ等はキュートメーターや主観的又は客観的な指標により測定できる。増加は,例えば,有意水準を5%とした統計学的有意差(例えばdunnett’s testやwilcoxonの符号付順位検定)を有する増加,及び/又は,例えば10%以上,20%以上,30%以上,40%以上,50%以上,60%以上,70%以上,80%以上,90%以上,100%以上の増加であってもよい。
Alternatively and / or additionally, the skin anti-aging effect may mean an increase in indicators such as skin viscoelasticity, elasticity, firmness, luster, smoothness, less noticeable pores, and less dullness according to the present invention. be. Skin viscoelasticity, elasticity, firmness, luster, smoothness, etc. can be measured by a cute meter or a subjective or objective index. The increase is, for example, an increase with a statistically significant difference (eg Dunnett's test or Wilcoxon signed rank test) with a significance level of 5%, and / or, for example, 10% or more, 20% or more, 30%. The increase may be 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 100% or more.
本発明は,表皮といった浅い層に好ましい作用を奏しながら,皮膚老化を予防・改善することができる。例えば,角化細胞におけるYAPの挙動やアクチンファイバーの構造を改善すること,特に,皮膚にアラビノキシランを有効成分として含む皮膚抗老化剤を適用した際や,物理刺激を与えた際の全角化細胞に対する核局在YAPやアクチンストレスファイバーを有する細胞数の割合の減少を抑制あるいはその後の増加を回復することができる。さらに,真皮におけるヒアルロン酸の増加,皮膚粘弾性や上記のような主観的又は客観的な指標の増加をもたらすこともできる。
The present invention can prevent and improve skin aging while exerting a favorable effect on a shallow layer such as the epidermis. For example, to improve the behavior of YAP and the structure of actin fibers in keratinized cells, especially for keratinized cells when a skin antiaging agent containing arabinoxylan as an active ingredient is applied to the skin or when physical stimulation is applied. It is possible to suppress the decrease in the proportion of cells having nuclear-localized YAP or actin stress fibers, or to recover the subsequent increase. In addition, it can lead to an increase in hyaluronic acid in the dermis, an increase in skin viscoelasticity and the above subjective or objective indicators.
また,本発明は,他の処置と併用してもよい。他の処置としては,例えば,光刺激,電気刺激,機械刺激,人の手による刺激といった刺激の適用,抗老化剤の投与,化粧料の塗布などが挙げられるがそれらに限定されない。抗老化剤は,天然または化学的に合成された化合物であってもよく,動植物の抽出物であってもよく,単体又は混合物,あるいは,水溶液等の溶媒中に含有された状態,化粧料などの形態であってもよい。また,抗老化剤の投与経路は任意に選択でき,例えば経口投与,経皮投与,皮下投与,経粘膜投与,筋肉内投与等が挙げられる。
Further, the present invention may be used in combination with other treatments. Other treatments include, but are not limited to, application of stimuli such as light stimulation, electrical stimulation, mechanical stimulation, human hand stimulation, administration of anti-aging agents, application of cosmetics, and the like. The anti-aging agent may be a naturally or chemically synthesized compound, an extract of animals and plants, a simple substance or a mixture, a state contained in a solvent such as an aqueous solution, cosmetics, etc. It may be in the form of. In addition, the administration route of the anti-aging agent can be arbitrarily selected, and examples thereof include oral administration, transdermal administration, subcutaneous administration, transmucosal administration, and intramuscular administration.
本発明は,美容,医療,ストレス緩和,リラックス等を目的とするものであってもよい。ある実施形態では,本発明は,美容を目的とするものであり,医師や医療従事者が使用するものではない場合がある。また,本発明は,本発明を対象に提示することを含む,対象の美容行為を支援する美容カウンセリング方法も提供する。
The present invention may be aimed at beauty, medical treatment, stress relief, relaxation, and the like. In certain embodiments, the present invention is intended for cosmetology and may not be used by physicians or healthcare professionals. The present invention also provides a cosmetology counseling method that supports a cosmetological act of the subject, including presenting the present invention to the subject.
本明細書において引用される全ての文献はその全体が引用により本明細書に援用される。
All documents cited herein are hereby incorporated by reference in their entirety.
次に実施例によって本発明をさらに詳細に説明する。本発明の実施例は例示のみを目的とし,本発明の技術的範囲を限定するものではない。本発明の技術的範囲は特許請求の範囲の記載によってのみ限定される。本発明の趣旨を逸脱しないことを条件として,本発明の変更,例えば,本発明の構成要件の追加,削除及び置換を行うことができる。
Next, the present invention will be described in more detail by way of examples. The examples of the present invention are for illustration purposes only and do not limit the technical scope of the present invention. The technical scope of the present invention is limited only by the description of the claims. The present invention may be modified, for example, the constituent elements of the present invention may be added, deleted or replaced, provided that the gist of the present invention is not deviated.
実験1:老化による角化細胞のin vitroの変化
試料:株式会社ケー・エー・シーから購入した年齢の異なるドナー(0歳,18歳,44歳,64歳)由来の単層培養角化細胞および線維芽細胞培養物を使用した。 Experiment 1: Changes in in vitro of keratinized cells due to aging Sample: Monolayer cultured keratinized cells from donors (0, 18, 44, 64 years old) of different ages purchased from KAC Co., Ltd. And fibroblast cultures were used.
試料:株式会社ケー・エー・シーから購入した年齢の異なるドナー(0歳,18歳,44歳,64歳)由来の単層培養角化細胞および線維芽細胞培養物を使用した。 Experiment 1: Changes in in vitro of keratinized cells due to aging Sample: Monolayer cultured keratinized cells from donors (0, 18, 44, 64 years old) of different ages purchased from KAC Co., Ltd. And fibroblast cultures were used.
伸展条件:Menicon Life Science社製のShellPaを使用し,上記の角化細胞および線維芽細胞に伸展刺激を与えた。伸展刺激は図1の下図中央に記載のような10%の伸展率で行った。サイクルは,図1上図左に記載のように,0.33%/sの伸展速度にて培養チェンバーを一方向に引っ張り,細胞を10%の伸展率まで伸展させた。その後,伸展状態を5分間維持し,0.33%/sの回復速度にて細胞を元の非伸展状態に戻した。これを1サイクルとし,合計27サイクルを3時間かけて行った。サイクル間での休止時間は0~10秒とした。
Stretching conditions: Using ShellPa manufactured by Menicon Life Science, stretch stimulation was given to the above-mentioned keratinocytes and fibroblasts. The extension stimulation was performed at an extension rate of 10% as shown in the center of the lower figure of FIG. In the cycle, as shown on the left side of the upper figure of FIG. 1, the culture chamber was pulled in one direction at an extension rate of 0.33% / s, and the cells were extended to an extension rate of 10%. Then, the extended state was maintained for 5 minutes, and the cells were returned to the original non-extended state at a recovery rate of 0.33% / s. This was regarded as one cycle, and a total of 27 cycles were performed over 3 hours. The rest time between cycles was 0 to 10 seconds.
観察方法:非伸展刺激および伸展刺激後の細胞内YAPを以下のように蛍光抗体染色法で観察した。細胞におけるYAPは抗YAP抗体(Santa Cruz Biotechnology, YAP抗体(63.7): sc-101199)用い,アクチンファイバーは蛍光化合物が架橋したファロイジン(ThermoFisher Scientific, Alexa FluorTM 488 Phalloidin: A12379)を用いて検出,共焦点レーザー顕微鏡(ZEISS, LSM700)により観察および画像取得した。また,画像処理解析ソフトウェアImageJを使用してYAPの核と細胞質比を蛍光強度の度合で数値化した。核と細胞質との蛍光強度比(核内YAPの蛍光強度/細胞質内YAPの蛍光強度)を算出し,その値が1≧のものを核内YAPを有する細胞としてその細胞数を計数した。全細胞数は,DAPI(Vector Laboratories, VECTASHIELD Mounting Medium with DAPI:H-1200)を用いて染色し,核が染まっている細胞の数を計数し,核局在YAPを有する細胞数の割合を式2に従って算出した。また,細胞質中や核周辺にあるアクチンストレスファイバーを1つでも含む細胞をアクチンストレスファイバーを有する細胞として計数し,同様に全細胞数を計数し,アクチンストレスファイバーを有する細胞数の割合を式3に従って算出した。
Observation method: The intracellular YAP after non-extension stimulation and extension stimulation was observed by the fluorescent antibody staining method as follows. YAP in cells uses anti-YAP antibody (Santa Cruz Biotechnology, YAP antibody (63.7): sc-10199), and actin fiber uses phalloidin (ThermoFisher Scientific, Alexa Fluor TM 488 P) cross-linked with a fluorescent compound. Detection, observation and image acquisition with a confocal laser scanning microscope (ZEISS, LSM700). In addition, the image processing analysis software ImageJ was used to quantify the nucleus-cytoplasm ratio of YAP by the degree of fluorescence intensity. The fluorescence intensity ratio between the nucleus and the cytoplasm (fluorescence intensity of nuclear YAP / fluorescence intensity of intracellular YAP) was calculated, and the number of cells whose value was 1 ≧ was counted as a cell having nuclear YAP. The total number of cells is stained using DAPI (Vector Laboratories, VECTASHIELD Mounting Medium with DAPI: H-1200), the number of cells stained with nuclei is counted, and the ratio of the number of cells having nuclear localized YAP is calculated. Calculated according to 2. In addition, cells containing at least one actin stress fiber in the cytoplasm or around the nucleus are counted as cells having actin stress fiber, the total number of cells is counted in the same manner, and the ratio of the number of cells having actin stress fiber is calculated by Equation 3. Calculated according to.
結果:
角化細胞の顕微鏡写真を図2a,bに示す。これらの図からわかるように,若年層のドナー(0歳,18歳)から得た角化細胞では,伸展刺激の有り無しのいずれの条件においてもほぼ全ての細胞でYAPが核に局在するが,中高年層のドナー(44歳,64歳)から得た角化細胞では,伸展刺激を与えると核局在YAPを有する細胞数が急激に減少した。図3は,角化細胞における核局在YAPを有する細胞数の割合を示す。若年層では核局在YAPを有する細胞の数に変化は見られないものの,高齢者の角化細胞では有意に減少した。しかしながら,激減はしたものの核局在YAPを有する細胞数はゼロにはならず一定の割合で存在していた。角化細胞におけるアクチンストレスファイバーを有する細胞数の割合を示す図4では,若年層ではアクチンストレスファイバーを有する細胞の数に変化は見られず,高齢者の角化細胞では有意に減少しほぼ見られなくなった。一方,線維芽細胞では,図5に示すように,伸展刺激の有り無しの条件においてYAPやアクチンストレスファイバーに変化は見られず,年齢差もほとんど見られなかった。 result:
Micrographs of keratinocytes are shown in FIGS. 2a and 2b. As can be seen from these figures, in keratinocytes obtained from young donors (0 and 18 years old), YAP is localized in the nucleus in almost all cells with and without extension stimulation. However, in the keratinocytes obtained from middle-aged and elderly donors (44 years old and 64 years old), the number of cells having nuclear-localized YAP decreased sharply when extension stimulation was given. FIG. 3 shows the percentage of cells having nuclear localization YAP in keratinocytes. Although there was no change in the number of cells with nuclear localization YAP in the younger generation, it was significantly decreased in the keratinized cells in the elderly. However, although the number decreased sharply, the number of cells having nuclear localization YAP did not become zero and existed at a constant rate. In FIG. 4, which shows the ratio of the number of cells having actin stress fibers in the keratinocytes, there is no change in the number of cells having actin stress fibers in the younger generation, and it is significantly decreased in the keratinocytes in the elderly. I can't do it anymore. On the other hand, in fibroblasts, as shown in FIG. 5, no change was observed in YAP and actin stress fibers under the condition with and without extension stimulation, and almost no age difference was observed.
角化細胞の顕微鏡写真を図2a,bに示す。これらの図からわかるように,若年層のドナー(0歳,18歳)から得た角化細胞では,伸展刺激の有り無しのいずれの条件においてもほぼ全ての細胞でYAPが核に局在するが,中高年層のドナー(44歳,64歳)から得た角化細胞では,伸展刺激を与えると核局在YAPを有する細胞数が急激に減少した。図3は,角化細胞における核局在YAPを有する細胞数の割合を示す。若年層では核局在YAPを有する細胞の数に変化は見られないものの,高齢者の角化細胞では有意に減少した。しかしながら,激減はしたものの核局在YAPを有する細胞数はゼロにはならず一定の割合で存在していた。角化細胞におけるアクチンストレスファイバーを有する細胞数の割合を示す図4では,若年層ではアクチンストレスファイバーを有する細胞の数に変化は見られず,高齢者の角化細胞では有意に減少しほぼ見られなくなった。一方,線維芽細胞では,図5に示すように,伸展刺激の有り無しの条件においてYAPやアクチンストレスファイバーに変化は見られず,年齢差もほとんど見られなかった。 result:
Micrographs of keratinocytes are shown in FIGS. 2a and 2b. As can be seen from these figures, in keratinocytes obtained from young donors (0 and 18 years old), YAP is localized in the nucleus in almost all cells with and without extension stimulation. However, in the keratinocytes obtained from middle-aged and elderly donors (44 years old and 64 years old), the number of cells having nuclear-localized YAP decreased sharply when extension stimulation was given. FIG. 3 shows the percentage of cells having nuclear localization YAP in keratinocytes. Although there was no change in the number of cells with nuclear localization YAP in the younger generation, it was significantly decreased in the keratinized cells in the elderly. However, although the number decreased sharply, the number of cells having nuclear localization YAP did not become zero and existed at a constant rate. In FIG. 4, which shows the ratio of the number of cells having actin stress fibers in the keratinocytes, there is no change in the number of cells having actin stress fibers in the younger generation, and it is significantly decreased in the keratinocytes in the elderly. I can't do it anymore. On the other hand, in fibroblasts, as shown in FIG. 5, no change was observed in YAP and actin stress fibers under the condition with and without extension stimulation, and almost no age difference was observed.
実験2:老化による角化細胞のex vivoの変化
試料:Genoskin社から得たex vivoヒト腹部皮膚組織片(NativeSkin, 12well size,直径約1cm)を使用した。組織片は38歳のものである。
伸展条件:図6に示すようなプラスチック製の押圧部を作成した。押圧部の底面が試料の上面に押圧されるように試料の上部から垂直に押し下げて,0.1%以下の伸展率で皮膚が伸展されるように調整した。このような押下運動を図7に示すように10%/sの速度で行い,その後押圧部を保持して10秒間伸展状態を維持し,10%/sの速度で持ち上げて元の非伸展状態に戻し,次の押下運動まで10秒間休止した。これを1サイクルとし,90サイクルを30分間かけて行った。この90サイクルを1セットとし,セット間に30分~1時間の休止時間を設けて合計3セットの押下運動(合計270サイクル)を行った。 Experiment 2: Changes in ex vivo of keratinized cells due to aging Sample: Ex vivo human abdominal skin tissue pieces (NativeSkin, 12well size, about 1 cm in diameter) obtained from Genoskin were used. The piece of tissue is 38 years old.
Extension conditions: A plastic pressing portion as shown in FIG. 6 was created. The bottom surface of the pressing portion was pressed vertically from the top of the sample so as to be pressed against the top surface of the sample, and the skin was adjusted to be stretched at an extension rate of 0.1% or less. Such a pressing motion is performed at a speed of 10% / s as shown in FIG. 7, then the pressing portion is held and the extended state is maintained for 10 seconds, and then lifted at a speed of 10% / s to the original non-extended state. It was returned to, and rested for 10 seconds until the next pressing exercise. This was regarded as one cycle, and 90 cycles were carried out over 30 minutes. These 90 cycles were regarded as one set, and a total of 3 sets of pressing exercises (total of 270 cycles) were performed with a rest period of 30 minutes to 1 hour between sets.
試料:Genoskin社から得たex vivoヒト腹部皮膚組織片(NativeSkin, 12well size,直径約1cm)を使用した。組織片は38歳のものである。
伸展条件:図6に示すようなプラスチック製の押圧部を作成した。押圧部の底面が試料の上面に押圧されるように試料の上部から垂直に押し下げて,0.1%以下の伸展率で皮膚が伸展されるように調整した。このような押下運動を図7に示すように10%/sの速度で行い,その後押圧部を保持して10秒間伸展状態を維持し,10%/sの速度で持ち上げて元の非伸展状態に戻し,次の押下運動まで10秒間休止した。これを1サイクルとし,90サイクルを30分間かけて行った。この90サイクルを1セットとし,セット間に30分~1時間の休止時間を設けて合計3セットの押下運動(合計270サイクル)を行った。 Experiment 2: Changes in ex vivo of keratinized cells due to aging Sample: Ex vivo human abdominal skin tissue pieces (NativeSkin, 12well size, about 1 cm in diameter) obtained from Genoskin were used. The piece of tissue is 38 years old.
Extension conditions: A plastic pressing portion as shown in FIG. 6 was created. The bottom surface of the pressing portion was pressed vertically from the top of the sample so as to be pressed against the top surface of the sample, and the skin was adjusted to be stretched at an extension rate of 0.1% or less. Such a pressing motion is performed at a speed of 10% / s as shown in FIG. 7, then the pressing portion is held and the extended state is maintained for 10 seconds, and then lifted at a speed of 10% / s to the original non-extended state. It was returned to, and rested for 10 seconds until the next pressing exercise. This was regarded as one cycle, and 90 cycles were carried out over 30 minutes. These 90 cycles were regarded as one set, and a total of 3 sets of pressing exercises (total of 270 cycles) were performed with a rest period of 30 minutes to 1 hour between sets.
観察方法:伸展刺激の有り無しの条件において,YAPおよびDAPIを実験1と同様の方法で染色,観察,および画像取得を行った。
Observation method: YAP and DAPI were stained, observed, and imaged in the same manner as in Experiment 1 under the conditions with and without extension stimulation.
結果:
実験1でみられた老化によるYAPの挙動の変化はex vivoの試料でも同様に見られた。図8に見られるように,中高年層のドナー(38歳)から得たex vivo皮膚モデルにおいても表皮内の角化細胞では,伸展刺激を与えると核局在YAPが減少し染色されない部分が多くみられた。特に基底層近辺でこのような変化が著しかった。 result:
The change in YAP behavior due to aging observed inExperiment 1 was also observed in the ex vivo sample. As can be seen in FIG. 8, even in the ex vivo skin model obtained from a middle-aged donor (38 years old), in the keratinocytes in the epidermis, the nuclear localization YAP decreased and many parts were not stained when the extension stimulation was given. It was seen. Such changes were particularly remarkable near the basal layer.
実験1でみられた老化によるYAPの挙動の変化はex vivoの試料でも同様に見られた。図8に見られるように,中高年層のドナー(38歳)から得たex vivo皮膚モデルにおいても表皮内の角化細胞では,伸展刺激を与えると核局在YAPが減少し染色されない部分が多くみられた。特に基底層近辺でこのような変化が著しかった。 result:
The change in YAP behavior due to aging observed in
実験3:伸展刺激による角化細胞におけるin vitroの効果
試料:実験1と同じ中高年層のドナー(44歳)の角化細胞の単層培養物を使用した。
伸展条件:実験1と同じ伸展刺激を与えた。つまり,実験1で行った27サイクルの伸展刺激のセットを与えた。しかし,27サイクルからなる1セットの伸展刺激を3時間与えてから12~24時間経った後,試料に更に同じ伸展刺激を与え合計2セット行った。 Experiment 3: Effect of in vitro on keratinocytes by extension stimulation Sample: A monolayer culture of keratinocytes of the same middle-aged donor (44 years old) as inExperiment 1 was used.
Extension conditions: The same extension stimulus as inExperiment 1 was applied. That is, a set of 27 cycles of extension stimulation performed in Experiment 1 was given. However, 12 to 24 hours after giving one set of extension stimuli consisting of 27 cycles for 3 hours, the same extension stimulus was further given to the sample, and a total of two sets were performed.
試料:実験1と同じ中高年層のドナー(44歳)の角化細胞の単層培養物を使用した。
伸展条件:実験1と同じ伸展刺激を与えた。つまり,実験1で行った27サイクルの伸展刺激のセットを与えた。しかし,27サイクルからなる1セットの伸展刺激を3時間与えてから12~24時間経った後,試料に更に同じ伸展刺激を与え合計2セット行った。 Experiment 3: Effect of in vitro on keratinocytes by extension stimulation Sample: A monolayer culture of keratinocytes of the same middle-aged donor (44 years old) as in
Extension conditions: The same extension stimulus as in
観察方法:非伸展刺激および伸展刺激後のYAPは実験1と同様に染色した。また,増殖マーカーとしてBrdUを,抗BrdU抗体(Abcam, Anti-BrdU 抗体 [BU1/75 (ICR1)]: ab6326)を用いて蛍光抗体法により染色した。BrdUの処理は6時間行い,その7日後に4%パラホルムアルデヒドを用いて4℃にて24時間固定した。固定した試料を共焦点レーザー顕微鏡(ZEISS, LSM700)を用いて観察および画像取得を行った。
Observation method: YAP after non-extension stimulation and extension stimulation was stained in the same manner as in Experiment 1. In addition, BrdU was stained with an anti-BrdU antibody (Abcam, Anti-BrdU antibody [BU1 / 75 (ICR1)]: ab6326) as a growth marker by the fluorescent antibody method. The treatment of BrdU was carried out for 6 hours, and 7 days later, it was fixed at 4 ° C. for 24 hours with 4% paraformaldehyde. The fixed sample was observed and imaged using a confocal laser scanning microscope (ZEISS, LSM700).
結果を図9に示す。1回目の伸展刺激では,実験1と同様,伸展刺激前後で核局在YAPを有する細胞数に大きな変化があった。BrdUも核局在YAPと同様に伸展刺激により激減した。一方,1回目の伸展刺激から24時間後に2回目の伸展刺激を与えた場合,核局在YAPおよびBrdUは,非伸展刺激条件と2回伸展刺激条件の間で大きな変化が見られないかやや増加していた。核局在YAPと増殖細胞には何らかの関連性があることが示唆されかつ,1回の伸展刺激よりも2回の伸展刺激を与えた後の細胞は,自己複製能をもつ細胞が増加しており,非伸展あるいは若年の角化細胞と同様の細胞増殖能を回復あるいは維持していることが示唆される。理論に拘束されるものではないが,1回目の伸展刺激により,増殖維持や自己複製能の低い老化角化細胞の細胞死が促進されるか,剥がれ落ちるといった何らかの機構により,老化角化細胞を選択的に排除し,増殖維持や自己複製能の高い核局在YAPを示す細胞を選択的に残すことにより角化細胞の増殖や回復を促している可能性が考えられる。
The results are shown in Fig. 9. In the first extension stimulus, as in Experiment 1, there was a large change in the number of cells having nuclear localization YAP before and after the extension stimulus. BrdU also decreased sharply due to extension stimulation, similar to nuclear localization YAP. On the other hand, when the second extension stimulus was given 24 hours after the first extension stimulus, the nuclear localization YAP and BrdU showed no significant change between the non-extension stimulus condition and the second extension stimulus condition. It was increasing. It has been suggested that there is some relationship between nuclear localized YAP and proliferation cells, and the number of cells capable of self-renewal increases in cells after two extension stimuli are given rather than one extension stimulus. It is suggested that the cell proliferation ability is restored or maintained similar to that of non-extended or young keratinocytes. Although not bound by theory, the first extension stimulation promotes cell death of aging keratinocytes with low growth maintenance and self-renewal ability, or causes aging keratinocytes to peel off by some mechanism. It is considered that the proliferation and recovery of keratinocytes are promoted by selectively eliminating cells showing nuclear-localized YAP having high growth maintenance and self-renewal ability.
実験4:伸展刺激による表皮におけるex vivoの効果
試料:Genoskin社から購入した中高年層のドナー(42歳)のex vivoヒト腹部皮膚組織片(NativeSkin, 6well size,直径約2~2.5cm)を使用した。
伸展条件:図10に示すようなウェル内の皮膚の両端を把持する把持部を有し,把持部を引っ張ることにより皮膚を伸展させる伸展器具を作成した。上記組織片が入ったウェルを水平に設置し,把持部を操作して両端から皮膚を伸展させ図7に示すように10%の伸展率となる伸展を10%/sの速度で行い,10%/sの回復速度にて試料を元の非伸展状態に戻した。これを1サイクルとし,合計90サイクルを30分間かけて行った。この90サイクルを1セットとし,セット間に30分~1時間の休止時間を設けて合計3セット(合計270サイクル)行った。この3セットの伸展刺激を3時間与えてから12~24時間経った後,試料に更に同じ3セットの伸展刺激を2日連続で2回行った。 Experiment 4: Effect of ex vivo on epidermis by extension stimulation Sample: Ex vivo human abdominal skin tissue piece (NativeSkin, 6well size, about 2 to 2.5 cm in diameter) of a middle-aged donor (42 years old) purchased from Genoskin. used.
Stretching conditions: A stretching device having grips for gripping both ends of the skin in the well as shown in FIG. 10 and stretching the skin by pulling the grips was created. The well containing the above tissue piece was placed horizontally, and the grip portion was operated to stretch the skin from both ends, and as shown in FIG. 7, stretching with a stretching rate of 10% was performed at a rate of 10% / s. The sample was returned to its original non-extended state at a recovery rate of% / s. This was regarded as one cycle, and a total of 90 cycles were performed over 30 minutes. These 90 cycles were regarded as one set, and a total of 3 sets (270 cycles in total) were performed with a rest time of 30 minutes to 1 hour between the sets. After 12 to 24 hours after giving these 3 sets of extension stimuli for 3 hours, the same 3 sets of extension stimuli were further applied to the sample twice for 2 consecutive days.
試料:Genoskin社から購入した中高年層のドナー(42歳)のex vivoヒト腹部皮膚組織片(NativeSkin, 6well size,直径約2~2.5cm)を使用した。
伸展条件:図10に示すようなウェル内の皮膚の両端を把持する把持部を有し,把持部を引っ張ることにより皮膚を伸展させる伸展器具を作成した。上記組織片が入ったウェルを水平に設置し,把持部を操作して両端から皮膚を伸展させ図7に示すように10%の伸展率となる伸展を10%/sの速度で行い,10%/sの回復速度にて試料を元の非伸展状態に戻した。これを1サイクルとし,合計90サイクルを30分間かけて行った。この90サイクルを1セットとし,セット間に30分~1時間の休止時間を設けて合計3セット(合計270サイクル)行った。この3セットの伸展刺激を3時間与えてから12~24時間経った後,試料に更に同じ3セットの伸展刺激を2日連続で2回行った。 Experiment 4: Effect of ex vivo on epidermis by extension stimulation Sample: Ex vivo human abdominal skin tissue piece (NativeSkin, 6well size, about 2 to 2.5 cm in diameter) of a middle-aged donor (42 years old) purchased from Genoskin. used.
Stretching conditions: A stretching device having grips for gripping both ends of the skin in the well as shown in FIG. 10 and stretching the skin by pulling the grips was created. The well containing the above tissue piece was placed horizontally, and the grip portion was operated to stretch the skin from both ends, and as shown in FIG. 7, stretching with a stretching rate of 10% was performed at a rate of 10% / s. The sample was returned to its original non-extended state at a recovery rate of% / s. This was regarded as one cycle, and a total of 90 cycles were performed over 30 minutes. These 90 cycles were regarded as one set, and a total of 3 sets (270 cycles in total) were performed with a rest time of 30 minutes to 1 hour between the sets. After 12 to 24 hours after giving these 3 sets of extension stimuli for 3 hours, the same 3 sets of extension stimuli were further applied to the sample twice for 2 consecutive days.
観察方法:非伸展刺激0日目,伸展刺激直後(同0日目),非伸展刺激,伸展刺激処理した皮膚組織を1週間培養した後に,実験1と同様のYAPとDAPI処理を行い,更に増殖マーカーとしてKi67を抗Ki67抗体(Abcam, Anti-Ki67 抗体 [SP6]: ab16667)を用いて染色を行い,実験1と同様の手順で観察および画像取得を行った。
Observation method: On the 0th day of the non-extension stimulation, immediately after the extension stimulation (the 0th day of the same), after culturing the skin tissue treated with the non-extension stimulation and the extension stimulation for 1 week, the same YAP and DAPI treatment as in Experiment 1 was performed, and further. Ki67 was stained with an anti-Ki67 antibody (Abcam, Anti-Ki67 antibody [SP6]: ab16667) as a growth marker, and observation and image acquisition were performed in the same procedure as in Experiment 1.
図11に非伸展刺激0日目および伸展刺激直後(同0日目)の様子を示す。YAPを有する基底層の表皮細胞が減少し,増殖マーカーKi67は引張直後に増えていた。理論に拘束されるものではないが,伸展刺激により細胞増殖とその後の細胞分化の過程を促進した可能性も考えられる。図12に伸展刺激を2日連続で2回与えた後に1週間培養した後の様子を示す。伸展前では,基底層のみならず表皮細胞全体にわたりYAPが見られた。YAPは,通常基底層に多くみられるが,1週間培養した皮膚では全層にわたり観察された。理論に拘束されるものではないが,非伸展の皮膚組織では,細胞老化により,例えば,表皮内の各層における細胞増殖や細胞分化に何かしらの異常が起こり,YAPの分布が変化している可能性も考えられる。しかしながら,2回の伸展刺激後YAPの発現分布は基底層に維持されていた。理論に拘束されるものではないが,物理刺激により,表皮における細胞増殖,細胞分化のホメオスタシスが活性化,維持された結果,YAPの分布が1週間の培養後でも初期の新鮮な皮膚組織の通常状態を維持している可能性も考えられる。
FIG. 11 shows the state of the non-extension stimulation on the 0th day and immediately after the extension stimulation (the 0th day). The number of epidermal cells in the basal layer having YAP decreased, and the proliferation marker Ki67 increased immediately after tension. Although not bound by theory, it is possible that stretching stimulation promoted the process of cell proliferation and subsequent cell differentiation. FIG. 12 shows the state after culturing for 1 week after giving the extension stimulus twice for 2 consecutive days. Before extension, YAP was observed not only in the basal layer but also in the entire epidermal cells. YAP is usually abundant in the basal layer, but was observed in all layers of skin cultured for 1 week. Although not bound by theory, in non-extended skin tissue, cell aging may cause, for example, some abnormalities in cell proliferation and cell differentiation in each layer of the epidermis, resulting in altered YAP distribution. Is also possible. However, the expression distribution of YAP was maintained in the basal lamina after two stretching stimuli. Although not bound by theory, physical stimulation activates and maintains homeostasis of cell proliferation and cell differentiation in the epidermis, resulting in a normal distribution of YAP in early fresh skin tissue even after 1 week of culture. It is also possible that the condition is maintained.
実験5:伸展刺激による真皮におけるex vivoの効果
試料および伸展条件:実験4と同じGenoskin社から購入した中高年層のドナー(44歳)のex vivoヒト腹部皮膚組織片(NativeSkin,6well size,直径約2~2.5cm)を使用した。実験4と同じ伸展である3セットの伸展刺激を2日連続で2回行った。 Experiment 5: Effect of ex vivo on dermis by extension stimulation Sample and extension conditions: Ex vivo human abdominal skin tissue piece (NativeSkin, 6well size, about diameter) of a middle-aged donor (44 years old) purchased from the same Genoskin company as inExperiment 4. 2 to 2.5 cm) was used. Three sets of extension stimulation, which is the same extension as in Experiment 4, was performed twice for two consecutive days.
試料および伸展条件:実験4と同じGenoskin社から購入した中高年層のドナー(44歳)のex vivoヒト腹部皮膚組織片(NativeSkin,6well size,直径約2~2.5cm)を使用した。実験4と同じ伸展である3セットの伸展刺激を2日連続で2回行った。 Experiment 5: Effect of ex vivo on dermis by extension stimulation Sample and extension conditions: Ex vivo human abdominal skin tissue piece (NativeSkin, 6well size, about diameter) of a middle-aged donor (44 years old) purchased from the same Genoskin company as in
観察方法:伸展刺激前,伸展刺激後1週間培養した後のDAPI,ヒアルロン酸(HOKUDO, Biotin-HABP: BC41),コラーゲン(Merck Millipore, Anti-human COL1N-terminal antibody: MAB1912)を観察した。DAPIは実験1と同様に,ヒアルロン酸,コラーゲンは蛍光抗体法により染色し共焦点レーザー顕微鏡(ZEISS, LSM700)により観察および画像取得した。
Observation method: DAPI, hyaluronic acid (HOKUDO, Biotin-HABP: BC41), collagen (Merck Millipore, Anti-human COL1N-terminal antibody: MAB1912) were observed before the extension stimulation and after culturing for 1 week after the extension stimulation. As for DAPI, hyaluronic acid and collagen were stained by the fluorescent antibody method as in Experiment 1, and observed and imaged with a confocal laser scanning microscope (ZEISS, LSM700).
結果を図13に示す。伸展刺激を与えた場合,真皮におけるヒアルロン酸が増加していた。伸展刺激により表皮細胞の増殖を促進するのみならず,真皮にも好ましい影響を与えていることが示される。
The results are shown in FIG. Hyaluronic acid in the dermis was increased when the extension stimulus was given. It is shown that the extension stimulation not only promotes the proliferation of epidermal cells but also has a favorable effect on the dermis.
実験6:コヒリス(商標)GR投与による角化細胞におけるin vitroの効果
試料:実験1と同じ中高年層のドナー(44歳)の角化細胞の単層培養物を使用し,伸展刺激開始の1日前にコヒリス(商標)GR(水(84.50%), ぺチレングリコール(10.00%), ライムギ種子エキス(5.50%))を0.3体積%および1.0体積%の濃度で角化細胞専用培地(Epilife, Thermo Fisher Scientific, HuMedia-KG増殖添加剤セット, クラボウ)に溶解した培養液にて正常ヒト角化細胞を1日培養した。コントロールには,(水(90.00%), ぺチレングリコール(10.00%))を0.3体積%および1.0体積%の濃度で角化細胞専用培地に溶解した培養液を用い,正常ヒト角化細胞を同様に培養した。
伸展条件:実験1と同じ伸展刺激を与えた。つまり,実験1で行った27サイクルの伸展刺激のセットを与えた。 Experiment 6: Effect of in vitro on keratinized cells by administration of Kohiris ™ GR Sample: Using a monolayer culture of keratinized cells of the same middle-aged donor (44 years old) as in Experiment 1, 1 of the initiation of extension stimulation A day ago, Kohiris ™ GR (water (84.50%), petylene glycol (10.00%), limegi seed extract (5.50%)) was added in 0.3% by volume and 1.0% by volume. Normal human keratinized cells were cultured for 1 day in a culture medium dissolved in a medium for exclusive use of keratinized cells (Epilife, Thermo Fisher Scientific, HuMedia-KG growth additive set, Kurabo). For control, a culture medium in which (water (90.00%), petylene glycol (10.00%)) was dissolved in a medium for keratinized cells at concentrations of 0.3% by volume and 1.0% by volume was used. , Normal human keratinized cells were cultured in the same manner.
Extension conditions: The same extension stimulus as inExperiment 1 was applied. That is, a set of 27 cycles of extension stimulation performed in Experiment 1 was given.
試料:実験1と同じ中高年層のドナー(44歳)の角化細胞の単層培養物を使用し,伸展刺激開始の1日前にコヒリス(商標)GR(水(84.50%), ぺチレングリコール(10.00%), ライムギ種子エキス(5.50%))を0.3体積%および1.0体積%の濃度で角化細胞専用培地(Epilife, Thermo Fisher Scientific, HuMedia-KG増殖添加剤セット, クラボウ)に溶解した培養液にて正常ヒト角化細胞を1日培養した。コントロールには,(水(90.00%), ぺチレングリコール(10.00%))を0.3体積%および1.0体積%の濃度で角化細胞専用培地に溶解した培養液を用い,正常ヒト角化細胞を同様に培養した。
伸展条件:実験1と同じ伸展刺激を与えた。つまり,実験1で行った27サイクルの伸展刺激のセットを与えた。 Experiment 6: Effect of in vitro on keratinized cells by administration of Kohiris ™ GR Sample: Using a monolayer culture of keratinized cells of the same middle-aged donor (44 years old) as in
Extension conditions: The same extension stimulus as in
観察方法:非伸展刺激および伸展刺激後の細胞内YAPを実験1と同様の方法で染色,観察し,核局在YAPを有する細胞数の割合とアクチンストレスファイバーを有する細胞数の割合を算出した。
Observation method: The intracellular YAP after non-extension stimulation and extension stimulation was stained and observed in the same manner as in Experiment 1, and the ratio of the number of cells having nuclear localized YAP and the ratio of the number of cells having actin stress fiber were calculated. ..
結果:
結果を図15に示す。実験1で示すように,中高年のドナー(44歳)から得た角化細胞では,伸展刺激を与えると核局在YAPを有する細胞数の割合とアクチンストレスファイバーを有する細胞数の割合が急激に減少するが,コヒリス(商標)GRを添加することにより,いずれの割合も伸展刺激前と同程度であり,1%投与の場合アクチンストレスファイバーを有する細胞数の割合が伸展刺激前より高くなっていた。 result:
The results are shown in FIG. As shown inExperiment 1, in the keratinized cells obtained from a middle-aged donor (44 years old), the ratio of the number of cells having nuclear localized YAP and the ratio of the number of cells having actin stress fiber suddenly increased when extension stimulation was given. Although it decreased, by adding Kohiris ™ GR, all the ratios were about the same as before the extension stimulation, and when 1% was administered, the ratio of the number of cells having actin stress fibers was higher than before the extension stimulation. rice field.
結果を図15に示す。実験1で示すように,中高年のドナー(44歳)から得た角化細胞では,伸展刺激を与えると核局在YAPを有する細胞数の割合とアクチンストレスファイバーを有する細胞数の割合が急激に減少するが,コヒリス(商標)GRを添加することにより,いずれの割合も伸展刺激前と同程度であり,1%投与の場合アクチンストレスファイバーを有する細胞数の割合が伸展刺激前より高くなっていた。 result:
The results are shown in FIG. As shown in
実験7:伸展刺激によるin vivoの効果
被験者:健康な30~50代の女性17名を選定した。
伸展条件:図14左に記載の伸展装置を使用した。この装置は,図14左の矢印で示す皮膚接触部が皮膚に触れ,皮膚固定部が皮膚を固定しつつ皮膚伸展部の皮膚に対する垂直方向押し込み量を最大約5mmの範囲で適宜設定することで水平方向の伸展率が0.1~20%となるようにし,皮膚を1.2Hzの振動数で伸展するように設計されている。被験者は半顔にこの装置を適用することで伸展刺激を毎日30分与える操作を10日間行った。 Experiment 7: Effect of in vivo by extension stimulation Subjects: 17 healthy women in their 30s and 50s were selected.
Extension conditions: The extension device shown on the left side of FIG. 14 was used. In this device, the skin contact part indicated by the arrow on the left of FIG. 14 touches the skin, and the skin fixing part fixes the skin while appropriately setting the amount of vertical pushing of the skin extension part with respect to the skin within a range of a maximum of about 5 mm. It is designed to stretch the skin at a frequency of 1.2 Hz with a horizontal stretch rate of 0.1 to 20%. The subject applied this device to the half face to give a stretching stimulus for 30 minutes every day for 10 days.
被験者:健康な30~50代の女性17名を選定した。
伸展条件:図14左に記載の伸展装置を使用した。この装置は,図14左の矢印で示す皮膚接触部が皮膚に触れ,皮膚固定部が皮膚を固定しつつ皮膚伸展部の皮膚に対する垂直方向押し込み量を最大約5mmの範囲で適宜設定することで水平方向の伸展率が0.1~20%となるようにし,皮膚を1.2Hzの振動数で伸展するように設計されている。被験者は半顔にこの装置を適用することで伸展刺激を毎日30分与える操作を10日間行った。 Experiment 7: Effect of in vivo by extension stimulation Subjects: 17 healthy women in their 30s and 50s were selected.
Extension conditions: The extension device shown on the left side of FIG. 14 was used. In this device, the skin contact part indicated by the arrow on the left of FIG. 14 touches the skin, and the skin fixing part fixes the skin while appropriately setting the amount of vertical pushing of the skin extension part with respect to the skin within a range of a maximum of about 5 mm. It is designed to stretch the skin at a frequency of 1.2 Hz with a horizontal stretch rate of 0.1 to 20%. The subject applied this device to the half face to give a stretching stimulus for 30 minutes every day for 10 days.
測定方法:実験開始後3日目と10日目に伸展刺激を付与した(treated)及び付与しなかった(control)半顔毎の皮膚状態の測定を行った。皮膚状態の計測は,経皮水分蒸散量(TEWL)をDelfin Technologies社のバポメーターにより測定し,皮膚水分量をCourage+Khazaka社のコルネオメーター(CM825)により測定し,皮膚粘弾性をCourage+Khazaka社のキュートメーター(SEM575)により測定することにより行った。得られたデータはdunnett’s testで0日目の値とそれぞれを比較することにより統計処理を行った(*** :p<0.005, ** :p<0.01, *:p<0.05)。
Measurement method: On the 3rd and 10th days after the start of the experiment, the skin condition of each half face with and without stretching stimulation (treated) was measured. The skin condition is measured by measuring the percutaneous water evaporation (TEWL) with a vapor meter of Delfin Technologies, measuring the skin water with a Corneometer (CM825) of Course + Khazaka, and measuring the skin viscoelasticity with a cute meter (Courage + Khazaka). This was done by measuring with SEM575). The obtained data was statistically processed by comparing each with the value on the 0th day in Dunnett's test (***: p <0.005, **: p <0.01, *: p. <0.05).
更に,被験者は,伸展刺激を与える前と10日後の頬の印象を,下記に示す評価項目ごとに5段階評価にて記入することにより主観的な評価を行った。
主観的評価の結果は,wilcoxonの符号付順位検定により統計処理を行った(*** :p<0.005, ** :p<0.01, *:p<0.05)。
Furthermore, the subjects made a subjective evaluation by entering the impressions of the cheeks before and 10 days after the extension stimulus on a 5-point scale for each of the following evaluation items.
The results of the subjective evaluation were statistically processed by Wilcoxon signed rank test (***: p <0.005, **: p <0.01, *: p <0.05).
結果:結果を図16a~cに示す。図16aに示すようにTEWLおよび皮膚水分量のいずれも伸展刺激による変化はなかったが,図16bに示すようにキュートメーターによる測定ではR0値が有意に増加しており皮膚粘弾性が改善していることがわかった。この傾向はR2値及びR7値でも見られた。また,図16cに示すように見た目及び触感のいずれでも被験者は皮膚状態が改善されたことを実感していることが分かった。
Result: The results are shown in FIGS. 16a-c. As shown in FIG. 16a, neither TEWL nor the skin water content was changed by the extension stimulus, but as shown in FIG. 16b, the R0 value was significantly increased and the skin viscoelasticity was improved as measured by the cute meter. I found out that there is. This tendency was also seen in the R2 and R7 values. In addition, as shown in FIG. 16c, it was found that the subjects felt that the skin condition was improved in both the appearance and the tactile sensation.
実験8:押圧刺激によるex vivoの効果
試料:実験4と同じGenoskin社から購入した中高年層のドナー(44歳)のex vivoヒト腹部皮膚組織片(NativeSkin,6well size,直径約2~2.5cm)を使用した。 Experiment 8: Effect of ex vivo by pressing stimulus Sample: Ex vivo human abdominal skin tissue piece (NativeSkin, 6well size, about 2 to 2.5 cm in diameter) of a middle-aged donor (44 years old) purchased from the same Genoskin company as inExperiment 4. )It was used.
試料:実験4と同じGenoskin社から購入した中高年層のドナー(44歳)のex vivoヒト腹部皮膚組織片(NativeSkin,6well size,直径約2~2.5cm)を使用した。 Experiment 8: Effect of ex vivo by pressing stimulus Sample: Ex vivo human abdominal skin tissue piece (NativeSkin, 6well size, about 2 to 2.5 cm in diameter) of a middle-aged donor (44 years old) purchased from the same Genoskin company as in
押圧条件:誘電エラストマーアクチュエータ(住友理工株式会社製:SRHP074-001)を使用した。この誘電エラストマーアクチュエータは,図17左上に記載のようにこの誘電エラストマーアクチュエータを上記皮膚組織片に施し,収縮と拡張を繰り返すことにより,図17下部に記載の条件で各種波形の0~100μmの押圧刺激を0.5Hz,5Hz,又は50Hzの振動数で1日又は5日間与えた。
Pressing condition: Dielectric elastomer actuator (manufactured by Sumitomo Riko Co., Ltd .: SRHP074-001) was used. As shown in the upper left of FIG. 17, the dielectric elastomer actuator is applied to the skin tissue piece and repeatedly contracted and expanded to press various waveforms of 0 to 100 μm under the conditions described in the lower part of FIG. The stimulus was given at a frequency of 0.5 Hz, 5 Hz, or 50 Hz for 1 or 5 days.
観察方法:押圧刺激前,押圧刺激後のDAPI,Ki67を実験4と同様の方法で観察した。
Observation method: DAPI and Ki67 before and after the pressing stimulus were observed by the same method as in Experiment 4.
結果:
結果を図18,19に示す。押圧刺激を与えない場合(Cont:silent)1日目に比べ5日目のKi67の数が減少していたが,押圧刺激を与えた場合(0.5Hz/100μm:square),5日目の表皮細胞のKi67の減少が抑制されており,押圧刺激によって表皮細胞の増殖抑制が抑えられることが示された。また押圧刺激は0.5Hz程度の低い振動数のほうが5Hz,50Hzの場合に比べて高い効果を示した。なお,図18,19の結果は矩形波の場合(square)を示しているが正弦波(sin)の場合であっても同様の結果が得られた。 result:
The results are shown in FIGS. 18 and 19. When no pressing stimulus was given (Cont: cellent), the number of Ki67 on the 5th day decreased compared to the 1st day, but when the pressing stimulus was given (0.5Hz / 100μm: square), the number of Ki67 on the 5th day was reduced. It was shown that the decrease of Ki67 in epidermal cells was suppressed, and that the suppression of epidermal cell proliferation was suppressed by the pressing stimulus. In addition, the pressing stimulus showed a higher effect at a low frequency of about 0.5 Hz than at 5 Hz and 50 Hz. The results shown in FIGS. 18 and 19 show the case of a rectangular wave (square), but the same result was obtained even in the case of a sine wave (sin).
結果を図18,19に示す。押圧刺激を与えない場合(Cont:silent)1日目に比べ5日目のKi67の数が減少していたが,押圧刺激を与えた場合(0.5Hz/100μm:square),5日目の表皮細胞のKi67の減少が抑制されており,押圧刺激によって表皮細胞の増殖抑制が抑えられることが示された。また押圧刺激は0.5Hz程度の低い振動数のほうが5Hz,50Hzの場合に比べて高い効果を示した。なお,図18,19の結果は矩形波の場合(square)を示しているが正弦波(sin)の場合であっても同様の結果が得られた。 result:
The results are shown in FIGS. 18 and 19. When no pressing stimulus was given (Cont: cellent), the number of Ki67 on the 5th day decreased compared to the 1st day, but when the pressing stimulus was given (0.5Hz / 100μm: square), the number of Ki67 on the 5th day was reduced. It was shown that the decrease of Ki67 in epidermal cells was suppressed, and that the suppression of epidermal cell proliferation was suppressed by the pressing stimulus. In addition, the pressing stimulus showed a higher effect at a low frequency of about 0.5 Hz than at 5 Hz and 50 Hz. The results shown in FIGS. 18 and 19 show the case of a rectangular wave (square), but the same result was obtained even in the case of a sine wave (sin).
実験9:押圧刺激によるin vivoの効果
被験者:健康な30~50代の女性17名を選定した。
伸展条件:図20に記載の押圧装置,誘電エラストマーアクチュエータ(住友理工株式会社製:SRHP074-001)を使用した。この装置は,図20上に示す装置の皮膚接触部が10gfの力で皮膚を押し込むことにより,5Hzの振動数で100μmの深度にて図20下に示す矩形波の押圧刺激を皮膚に与えるように設計されている。図20に示すように,被験者の前腕内側部にこの装置を適用し押圧刺激を毎日30分与える操作を5日間行った。 Experiment 9: Effect of in vivo by pressing stimulus Subjects: 17 healthy women in their 30s and 50s were selected.
Extension conditions: The pressing device shown in FIG. 20 and a dielectric elastomer actuator (manufactured by Sumitomo Riko Co., Ltd .: SRHP074-001) were used. In this device, the skin contact portion of the device shown in FIG. 20 pushes the skin with a force of 10 gf, so that the pressing stimulus of the rectangular wave shown in the lower part of FIG. 20 is given to the skin at a frequency of 5 Hz and a depth of 100 μm. Is designed for. As shown in FIG. 20, this device was applied to the medial part of the forearm of the subject, and the operation of applying a pressing stimulus for 30 minutes every day was performed for 5 days.
被験者:健康な30~50代の女性17名を選定した。
伸展条件:図20に記載の押圧装置,誘電エラストマーアクチュエータ(住友理工株式会社製:SRHP074-001)を使用した。この装置は,図20上に示す装置の皮膚接触部が10gfの力で皮膚を押し込むことにより,5Hzの振動数で100μmの深度にて図20下に示す矩形波の押圧刺激を皮膚に与えるように設計されている。図20に示すように,被験者の前腕内側部にこの装置を適用し押圧刺激を毎日30分与える操作を5日間行った。 Experiment 9: Effect of in vivo by pressing stimulus Subjects: 17 healthy women in their 30s and 50s were selected.
Extension conditions: The pressing device shown in FIG. 20 and a dielectric elastomer actuator (manufactured by Sumitomo Riko Co., Ltd .: SRHP074-001) were used. In this device, the skin contact portion of the device shown in FIG. 20 pushes the skin with a force of 10 gf, so that the pressing stimulus of the rectangular wave shown in the lower part of FIG. 20 is given to the skin at a frequency of 5 Hz and a depth of 100 μm. Is designed for. As shown in FIG. 20, this device was applied to the medial part of the forearm of the subject, and the operation of applying a pressing stimulus for 30 minutes every day was performed for 5 days.
測定方法:実験開始前と7日目に押圧刺激を付与した及び付与しなかった前腕内側部の皮膚状態の測定を行った。皮膚状態の計測は,経皮水分蒸散量(TEWL)をDelfin Technologies社のバポメーターにより測定し,皮膚水分量をCourage+Khazaka社のコルネオメーター(CM825)により測定し,皮膚粘弾性をCourage+Khazaka社のキュートメーター(SEM575)により測定することにより行った。
Measurement method: The skin condition of the medial part of the forearm with and without the pressing stimulus was measured before the start of the experiment and on the 7th day. The skin condition is measured by measuring the percutaneous water evaporation (TEWL) with a vapor meter of Delfin Technologies, measuring the skin water with a Corneometer (CM825) of Course + Khazaka, and measuring the skin viscoelasticity with a cute meter (Courage + Khazaka). This was done by measuring with SEM575).
結果:結果を図21a~cに示す。TEWLおよび皮膚水分量のいずれも押圧刺激による変化はなかったが,キュートメーターの結果は,押圧刺激を与えないと7日目にはR0値が有意に減少したが押圧刺激を与えることによりその減少が抑えられており,粘弾性の改善が見られた。
Result: The results are shown in FIGS. 21a-c. Neither TEWL nor skin water content was changed by the pressure stimulus, but the results of the cute meter showed that the R0 value decreased significantly on the 7th day without the pressure stimulus, but it decreased by the pressure stimulus. Was suppressed, and improvement in viscoelasticity was observed.
本願発明を施した皮膚では,伸展刺激による老化細胞の選択的排除かつ核局在YAP,アクチンストレスファイバーを有する角化細胞の選択的保持が示唆された。また,それら選択された核局在YAP,アクチンストレスファイバーを有する角化細胞の細胞増殖を示唆する結果も得た。さらには角化細胞が存在する表皮のみならず,真皮におけるヒアルロン酸の量が増加していた。つまり,本発明を用いると,表皮のみならず真皮といった部分を含めた皮膚に対し抗老化作用を奏することが示唆される。実際にin vivoで本発明をヒトに適用すると皮膚の粘弾性や,はり,つや,くすみ,なめらかさといった見た目及び触感が改善した。
It was suggested that in the skin to which the present invention was applied, senescent cells were selectively eliminated by extension stimulation and keratinocytes having nuclear localized YAP and actin stress fibers were selectively retained. We also obtained results suggesting cell proliferation of keratinized cells having these selected nuclear localization YAPs and actin stress fibers. Furthermore, the amount of hyaluronic acid in the dermis as well as the epidermis where keratinocytes are present was increased. In other words, it is suggested that the present invention exerts an anti-aging effect not only on the epidermis but also on the skin including the dermis. When the present invention was actually applied to humans in vivo, the viscoelasticity of the skin, the appearance and tactile sensation such as elasticity, luster, dullness, and smoothness were improved.
Claims (12)
- アラビノキシランを有効成分として含む,皮膚抗老化剤であって、
皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させることを特徴とする、皮膚抗老化剤。 A skin anti-aging agent containing arabinoxylan as an active ingredient.
A skin anti-aging agent characterized by increasing cells with nuclear localized YAP and / or actin stress fibers that are reduced by physical stimulation in the skin. - 前記アラビノキシランが,ライムギ由来である,請求項1に記載の皮膚抗老化剤。 The skin anti-aging agent according to claim 1, wherein the arabinoxylan is derived from rye.
- 前記アラビノキシランが,コヒリス(商標)GR由来である,請求項1又は2に記載の皮膚抗老化剤。 The skin anti-aging agent according to claim 1 or 2, wherein the arabinoxylan is derived from Kohiris ™ GR.
- 皮膚において物理刺激により減少する核局在YAPを有する細胞及び/又はアクチンストレスファイバーを有する細胞を増加させる,皮膚抗老化のための美容方法であって,
(a)対象の皮膚に,請求項1~3のいずれか一項に記載の皮膚抗老化剤を適用すること,
を含む,美容方法。 A cosmetic method for skin anti-aging that increases cells with nuclear localized YAP and / or actin stress fibers that decrease with physical stimulation in the skin.
(A) Applying the skin anti-aging agent according to any one of claims 1 to 3 to the target skin,
Cosmetology methods, including. - 前記美容方法は,さらに,前記皮膚に対して微弱な物理刺激を適用する工程を含み、ここで前記物理刺激を適用する工程は、例えば、
(b-1)前記対象の皮膚を0.1%以上50.0%以下の伸展率まで伸展することであって,ここで,伸展率は,
で算出される;及び
(c-1)前記対象の皮膚を伸展状態から回復すること;
並びに/又は,
(b-2)前記対象の皮膚を,1μm~1000μm押圧すること;及び
(c-2)前記対象の皮膚を押圧状態から回復すること;
を含み,
ここで前記(b-1)及び(c-1)並びに/又は前記(b-2)及び(c-2)のサイクルが60Hz以下の振動数で実施される,
を含む、請求項4に記載の美容方法。 The cosmetological method further includes a step of applying a weak physical stimulus to the skin, wherein the step of applying the physical stimulus is, for example, for example.
(B-1) The target skin is stretched to a stretch rate of 0.1% or more and 50.0% or less, where the stretch rate is defined as.
And (c-1) recovering the subject's skin from the stretched state;
And / or
(B-2) Pressing the subject's skin by 1 μm to 1000 μm; and (c-2) Recovering the subject's skin from the pressed state;
Including
Here, the cycles (b-1) and (c-1) and / or the cycles (b-2) and (c-2) are carried out at a frequency of 60 Hz or less.
The beauty method according to claim 4, which comprises. - 前記サイクルを2~500サイクル行うセットを,1又は複数セット行う,請求項5に記載の美容方法。 The beauty method according to claim 5, wherein one or a plurality of sets are performed by performing the cycle from 2 to 500 cycles.
- 前記皮膚抗老化は,全角化細胞数に対する核局在YAPを有する細胞数の割合を指標として測定された場合,皮膚に前記美容方法を適用した後に伸展角化細胞で測定される核局在YAPを有する細胞数の割合が前記美容方法を適用する前と比べて増加することであり,ここで,核局在YAPを有する細胞数の割合は,
- 前記皮膚抗老化は,全角化細胞数に対するアクチンストレスファイバーを有する細胞数の割合を指標として測定された場合,皮膚に前記美容方法を適用した後に伸展角化細胞で測定されるアクチンストレスファイバーを有する細胞数の割合が増加することであり,ここで,アクチンストレスファイバーを有する細胞数の割合は,
- 請求項5又は6に記載の美容方法に適用するための美容装置であって,
前記装置は,
物理刺激を生ずる刺激発生部と,
刺激発生部で発生した物理刺激を皮膚に付与する刺激付与部とを備え,
ここで,前記装置は,皮膚に対して微弱な物理刺激を適用する工程を行うための装置であり,ここで当該工程は,例えば,
(i-1)前記皮膚を0.1%以上50.0%以下の伸展率まで伸展すること;及び
(ii-1)前記皮膚を伸展状態から回復すること;
並びに/又は,
(i-2)前記皮膚を1μm~1000μm押圧すること;及び
(ii-2)前記皮膚を押圧状態から回復すること;を含むサイクルを60Hz以下の振動数で行うことであり,
ここで,伸展率は,上記式1により算出される,
前記美容装置。 A cosmetological device for applying to the cosmetological method according to claim 5 or 6.
The device is
The stimulus generator that causes physical stimulus and
It is equipped with a stimulus-giving part that gives the physical stimulus generated in the stimulus-generating part to the skin.
Here, the device is a device for performing a step of applying a weak physical stimulus to the skin, and the step is described here, for example.
(I-1) Stretching the skin to a stretch rate of 0.1% or more and 50.0% or less; and (ii-1) Restoring the skin from the stretched state;
And / or
A cycle including (i-2) pressing the skin by 1 μm to 1000 μm; and (ii-2) recovering the skin from the pressed state; is performed at a frequency of 60 Hz or less.
Here, the extension rate is calculated by the above equation 1.
The beauty device. - 請求項9に記載の美容装置を対象の皮膚に適用することを含む,皮膚抗老化のための美容方法。 A beauty method for skin anti-aging, which comprises applying the beauty device according to claim 9 to the target skin.
- 皮膚におけるヒアルロン酸を増加するための,請求項4~8及び10のいずれか1項に記載の美容方法。 The cosmetological method according to any one of claims 4 to 8 and 10, for increasing hyaluronic acid in the skin.
- 請求項1~3のいずれか1項に記載の皮膚抗老化剤,請求項4~8及び10のいずれか1項に記載の美容方法又は請求項9に記載の美容装置を対象に提示することを含む,対象の美容行為を支援する美容カウンセリング方法。 The skin anti-aging agent according to any one of claims 1 to 3, the cosmetological method according to any one of claims 4 to 8 and 10, or the cosmetological device according to claim 9 is presented to the subject. Cosmetology counseling methods that support the subject's cosmetology, including.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180022669.9A CN115427009A (en) | 2020-04-20 | 2021-04-19 | Skin antiaging agent, skin antiaging cosmetic method and cosmetic device for the method |
JP2022517041A JPWO2021215411A1 (en) | 2020-04-20 | 2021-04-19 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020-075020 | 2020-04-20 | ||
JP2020075020 | 2020-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021215411A1 true WO2021215411A1 (en) | 2021-10-28 |
Family
ID=78269422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/015926 WO2021215411A1 (en) | 2020-04-20 | 2021-04-19 | Skin anti-aging agent, beautification method for skin anti-aging, and beautification instrument for use in method |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2021215411A1 (en) |
CN (1) | CN115427009A (en) |
WO (1) | WO2021215411A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009536185A (en) * | 2006-05-05 | 2009-10-08 | ロレアル | A combination of a tightening agent or tightening device and a sugar compound |
US20140301960A1 (en) * | 2012-11-14 | 2014-10-09 | Coty Germany Gmbh | Cosmetic composition for increasing hyaluronic acid synthesis in skin and its use for repairing wrinkles |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2900574B1 (en) * | 2006-05-05 | 2015-01-30 | Oreal | COMPOSITION COMPRISING A TENSOR AGENT AND A SACCHARIDE COMPOUND |
-
2021
- 2021-04-19 CN CN202180022669.9A patent/CN115427009A/en active Pending
- 2021-04-19 JP JP2022517041A patent/JPWO2021215411A1/ja active Pending
- 2021-04-19 WO PCT/JP2021/015926 patent/WO2021215411A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009536185A (en) * | 2006-05-05 | 2009-10-08 | ロレアル | A combination of a tightening agent or tightening device and a sugar compound |
US20140301960A1 (en) * | 2012-11-14 | 2014-10-09 | Coty Germany Gmbh | Cosmetic composition for increasing hyaluronic acid synthesis in skin and its use for repairing wrinkles |
Non-Patent Citations (2)
Title |
---|
AOYAMA YUI: "Special Feature, Latest Research on Skin Roughness and Sagging. Countering gravity by causing movements in stress fibers: COHELISS", FRAGRANCE JOURNAL, vol. 36, no. 11, 2008, pages 62 - 63 * |
YUKINA: "Beyond the common sense of skin care! ReFa's facial expression beauty method using "beauty equipment x cosmetics" ", MAQUIA ONLINE, 22 August 2018 (2018-08-22), XP055868103, Retrieved from the Internet <URL:https://maquia.hpplus.jp/blog/yukina_maquia/34597/> [retrieved on 20211201] * |
Also Published As
Publication number | Publication date |
---|---|
CN115427009A (en) | 2022-12-02 |
JPWO2021215411A1 (en) | 2021-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2012296465B2 (en) | Dermal rejuvenation compositions and methods | |
US11602496B2 (en) | Use of gingerone or derivatives thereof for reducing or delaying the signs of skin ageing | |
CN104666236A (en) | Moisturizing skincare mask | |
CN104069058B (en) | For the composition and method of making the same of crease-resistant skin care item | |
HUE031064T2 (en) | A method for the dermocosmetic treatment of skin by application of NGF-containing compositions | |
WO2020213745A1 (en) | Method and device for preventing skin aging | |
JP2024037928A (en) | Method, device, and anti-photoaging and/or dermal pigmentation inhibitor for preventing and/or improving photoaging and/or dermal pigmentation, screening method for anti-photoaging and/or dermal pigmentation inhibitors, evaluation method for anti-photoaging and/or dermal pigmentation-inhibiting cosmetic treatments, and evaluation method for photoaging and/or dermal pigmentation level | |
Park et al. | Efficacy and safety of a new microneedle patch for skin brightening: A Randomized, split‐face, single‐blind study | |
WO2005036989A1 (en) | Health food containing hyaluronic acid and dermatan sulfate | |
WO2021167097A1 (en) | Method for improving aging by activating arrector pili muscle cells | |
CN113365602A (en) | Cross-linked material | |
WO2021215411A1 (en) | Skin anti-aging agent, beautification method for skin anti-aging, and beautification instrument for use in method | |
KR20240120739A (en) | Combination of high molecular weight cross-linked hyaluronic acid and low molecular weight non-cross-linked hyaluronic acid | |
JP7325234B2 (en) | Evaluation method of degree of skin aging | |
WO2021215409A1 (en) | Agent for preventing and/or improving photoaging and/or dermal pigmentation, cosmetic method using same, and cosmetic device to be applied in said method | |
Liu | The Human Skin Microbiome A New Way to Beauty | |
WO2023022011A1 (en) | Beauty method | |
CN109125106A (en) | A kind of anti-wrinkle stoste and its promote to seep technical application in skin | |
KR20020054602A (en) | Skin Care Compositions containing crystalline inorganic minerals | |
Han et al. | The efficacy study of trinity permeation synergism on anti-aging | |
de Oliveira et al. | Stretch treatment: research focused on aesthetic biomedicine | |
JP2022119185A (en) | Agents and cosmetic methods for anti-photoaging, and screening method for anti-photoaging agent | |
JP2023504461A (en) | Peptides and compositions for use in cosmetics and pharmaceuticals | |
JP2018052842A (en) | Hyaluronan synthase expression promoter, hyaluronan production promoter, and anti-skin aging composition containing the same | |
CN110522668A (en) | A kind of micro-current antibacterial facial mask and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21792411 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022517041 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21792411 Country of ref document: EP Kind code of ref document: A1 |